integrated report year ended december responsible management forest resources report printed paper produced fsccertified sources accordance standards forest stewardship council international certification body dedicated promoting responsible forest stewardship controlled sources using nonvoc ink free mineral oilscorporate philosophy essence c n e n management providing value businesses otsukapeople creating new products corporate culture otsukas goal development total healthcare company better health worldwide message president ryukangodo otsukas story keeping corporate philosophy otsuka values ryukangodo sweat sweat recognize way otsukas strengths recognize way jissho actualization sozosei creativity strive value creation model otsuka otsuka group supports lives people worldwide wide range process innovative creative products including pharmaceuticals functional beverages functional discovering core value creation process generates foods dedicated cultivating dynamic corporate culture workplaces reflect substance something originality hard work vision healthcare company finding ways live harmony local communities otsuka groups approach sustainability practice natural environment contributing richer healthier lives materiality material issues feature unique total healthcare company message cfo grow jissho advancing unique actualization total healthcare company pharmaceutical business selfactualization nutraceutical business achievement completion achieve sustainability discovery truth health people quality environment measures covid otsukas goal governance corporate governance become indispensable contributor sozosei directors audit supervisory creativity board members peoples health worldwide discussion corporate governance pursuing compliance otsuka capable otsuka group aims indispensable contributor peoples health worldwide fulfilling delivering tax compliance risk management corporate philosophy every aspect operations commitment improving peoples health worldwide part unchanging value continue provide society operations esg content index encompass two core businesses pharmaceutical business provides comprehensive health financial nonfinancial highlights support diagnosis treatment diseases nutraceutical business helps people main data maintain improve daytoday health corporate information global network nutraceuticals nutrition pharmaceuticals group structure overview main operating companies disclosure otsuka group stock information otsuka holdings co ltd integrated report providing value businesses total healthcare company otsuka group contributes people 's health worldwide creating innovative products two core businesses pharmaceutical business aims address unmet medical needs nutraceutical business seeks fulfill yettobeimagined needs consumers providing value otsuka bringing health people worldwide unmet medical needs diagnosis treatment pharmaceutical business yettobeimagined needs maintaining improving daytoday health nutraceutical business otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsukas goal development total healthcare company grow pages otsuka group continuously developed total healthcare company providing products services lead resolution social issues aim bringing health people worldwide present pursuing otsuka based six otsuka 's strengths emphasis otsuka specified key material issues require focused prioritized efforts goal become indispensable contributor peoples health worldwide thereby contributing realization sustainable society sustainable society pharmaceutical business social wellbeing providing value become indispensable contributor bringing health total healthcare pages goal peoples health worldwide people worldwide physical mental wellbeing wellbeing nutraceutical business pages otsukas strengths pages achieve achieve sustainability pages founding present future cosmedics cosmetics medicine state health defined constitution world health organizationwho ylesolc ot sessenisub gnipoleved seussi laicos sserdda ytilairetam pharma ceuticals nutra chemicals ceuticals otc vvaalluuee ccrreeaattiioonn cosmedics mmooddeell ppaaggeess consumer clinical products nutrition medical diagnostics devices otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report message president q direction otsuka group headed medium long term seek company continues contribute determined advance global market society otherwise purpose unique total healthcare company third continuously advance company exist mediumterm management plan continuously created new concepts products pursue creation unique value healthcare total healthcare marshalling unique diverse businesses fields ranging maintaining improving dayto company contributes assets effectively connecting true day health diagnosis treatment diseases needs identified customer insights medium longterm basis envisioning sustainable society technology science also pioneered society economy years years fields overlapped derived various ahead aim become indispensable contributor businesses well niche fields thereby creating peoples health worldwide providing innovative new value responding unmet yettobe products services otsuka group imagined health needs produce leveraging strengths total healthcare based experiences strengths company q otsuka celebrate th anniversary september changed changed otsuka group across decades tatsuo higuchi joined otsuka revenues group carefully monitoring flexibly adapting changes president representative director ceo companies billion yen usd million time consider largest factor otsuka holdings co ltd exchange rate revenues fiscal continuous business operations years exceeded billion yen usd billion since foundation operating bases substantially increased japan hand basic mindset internationally managerial systems evolved altered otsuka group inherited three key peoples healthcare needs considerably messages leadership across several generations transformed based factors declining unchanged corporate culture ryukangodo first wish express empathy people afflicted affected birthrates aging populations lifestyle changes sweat recognize way jissho actualization promoted businesses capitalizing strengths sozosei creativity ryukangodo signifies process ways covid includes heartfelt gratitude healthcare confronting weaknesses strengths may decay discovering core substance something professionals others support fallen ill weaknesses become complacent hard work practice jissho means selfactualization hand weaknesses converted strengths achievement completion discovery insights gained understanding addressing truth sozosei pursuing otsuka world entering era change trends transforming economy society otsuka group accepted practiced new capable delivering progressing geopolitical risks advancement ai information communications things thereby creating new value free stereotypes easier said done example sozosei conventional ideas continuously advanced signifies creating something scratch technology heightened awareness environmental conservation declining birthrates aging populations countries mature economies addition new lifestyles work styles based remote operations becoming common driven covid pandemic otsuka group companies creates products services address consumer patient ryukangodo jissho sozosei needs contribute resolution social issues carefully monitor changes sweat recognize way actualization creativity process discovering selfactualization pursuing business environment market needs order provide new value core substance something achievement completion otsuka capable hard work discovery delivering unchanged mission focuses otsuka value creation guided us right practice truth th anniversary otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report message president also production new things leveraging samscajinarcjynarque become existing assets innovative ways ryukangodo jissho blockbuster development involved much trial sozosei interlinked rethinking creatively error overcome various obstacles daily hypothesizing implementing carrying pursuit achieve otsuka lead sozosei combination ryukangodo taken root corporate culture jissho otsuka group q initiatives taking lead innovation first perspective human resources business advance patient centricity digital foundation present predecessors innovation otsuka early adopter enabling produced products cater unmet market needs optimized clinical trials location patients become large group companies want realtime insights recruitment mentality employees also changed trials larger diverse patient populations always advise think innovation patient centricity extends end identify opportunities problems products example approval north america innovative mindset group company astex pharmaceuticals second perspective system leads inqovi orally administered hypomethylating agent q basic policy corporate governance otsuka group new innovation end crucial actively enables patients receive treatment home promote communication inside outside hope otsuka company excites corporate governance key elements taking measures internal controls across group establish network across disciplines people outside look forward seeing institutional design internal control management group companies including conservation areas free fixed ideas culture must also otsuka introduces next organizations survive transparency assets information security business continuity encourage employees try new ideas derived without individuals believe otsuka institutional design refers formulation planning consider legal compliance system even fail important company individuals pursue operation institutions board directors particularly crucial order operate diverse businesses learn failures apply learnings challenges would like audit supervisory board board around world therefore ensure compliance one illustration two perspectives fortify organization lead innovation directors otsuka holdings holds vigorous discussions organizational structures education operate practice initiatives pharmaceutical reflect different viewpoints including advance management transparency promote four outside directors diverse backgrounds proper governance systems information disclosure q otsuka group need order continue sustainable growth operations business activities performed board accordance japan 's corporate governance members properly audited monitored code continue proactive dialogue close collaboration among audit supervisory board investors external stakeholders otsuka group strongly committed quality social issues business words members internal audit department internal corporate governance pages commitment began words busaburo otsuka otsuka groups mission contribute control department accounting auditors founder otsuka expressed calligraphy upon maintenance promotion peoples health launching intravenous solutions business treatment diseases attitude pursue quality vital factory resolution social issues q message stakeholders th anniversary packaging manufacture business matches direction market putting un sustainable development goals otsuka group companies celebrate review businesses birdseye view consumers position recent years actions address th anniversary september group flexibly adapt changes necessary search commitment passed environmental issues sustained business operations century new possibilities adapting new normal group ever since quality regarded one companys developed group companies operating time us demonstrate true value otsuka group signifies important obligations set countries regions approximately unique total healthcare company satisfy new product quality quality goals tied materiality employees deeply grateful support needs prepare stages value chain climate change resource recycling stakeholders enabled achievements unchanged corporate philosophy otsukapeople entire group pursue quality conservation water conservation global economy society midst creating new products better health worldwide management multiple endeavoring achieve transformation covid pandemic amplified sincerely ask continued support guidance dimensions sustainable society harmonizing social issues also uncovered new issues must stakeholders based corporate business growth environmental philosophy aim contribute conservation groupwide peoples health addressing collaboration otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsukas story billion launched lonsurf equelle launched jinarc rexulti launched abilify maintena launched bodymaint since founding chemical raw material manufacturer otsuka group steadily developed providing products lead resolution social issues related established otsuka medical devices healthcare aligned societys expectations diversifying businesses launched samsca launched abilify launched innersignal revenue performance nutraceutical consumer products businesses pharmaceutical business billion founded otsuka seiyaku kogyobu launched futraful launched calorie mate launched pletaal launched ts started iv solutions business launched oronine ointment launched pocari sweat launched uft launched mucosta launched first internally launched oronamin c drink developed drugs mikelan meptin launched world 's first commercial retort pouch food started diagnostics product bon curry business established pharmaceutical research institute diversification business aimed resolution social issues higher incidence shift toward social issues clinical nutrition medical needs heat disorder nuclear families unmet medical needs skin health issues public health satisfied pharmaceuticals unbalanced diet diversified lifestyles stable supply development development development development minimally evidencebased development highquality iv sterilizers functional beverages retort pouch food providing total healthcare solutions diagnosis treatment invasive medical devices skincare products achieve solutions disinfectants food products products specialized treatment iv solutions oronine h pocari sweat calorie mate bon curry abilify samsca quick navi innersignal ulos biomimics ointment representative products medical pharma cosmedics devices clinical cn eru tt icra ls c po rn os du um cte sr clinical ceuticals consumer pharma diagnostics consumer diagnostics c po rn os du um cte sr diagnostics cosmedics nutrition otc nutrition products ceuticals products divers oifi fcation chemicals nc ul tin rii tc ioa nl otc nc ul tin rii tc ioa nl otc clinical cp eh ua tr im caa ls otc cp eh ua tr im caa ls c po rn os du um cte sr business chemicals chemicals clinical nutra otc nutrition otc nutrition certicals clinical chemicals cn eru tt icra ls chemicals chemicals cn eru tt icra ls chemicals nc ul tin rii tc ioa nl nutra chemicals nutrition otc nutra certicals chemicals certicals due change fiscal year results fiscal month transitional period ended december otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsukas strengths people source strengths since otsukas establishment employees pages global reach incorporating solutions social issues everywhere pursued business guided enduring corporate philosophy order bring core business processes health people worldwide determination employees developed many strengths six strengths described representative sample continue extending global reach addressing social issues eg heat disorders infectious diseases differ evolve day making best possible use strengths employees take new countryregion depending culture customs times going forward provide products services lead challenges fulfill potential order contribute better health worldwide resolution social issues many countriesregions iv solutions business overseas companies enduring corporate philosophy essence management passed practiced throughout group countriesregions pocari sweat available engage employees think act creatively without preconceived countriesregions countriesregions notions also support development embody tuberculosis drug deltyba available unique capabilities potential believe well engagement corporate philosophy displayed corporate philosophy essence management reflected prominently offices every country corporate culture brought us today build business pages otsuka tomorrow ability nurture enduring brands ryukangodo jissho sozosei developed brands unceasing efforts convey health value innovative products born creative process discovering selfactualization pursuing research development ability nurture brands developed activities leads sustainable core substance something achievement completion otsuka capable hard work discovery delivering growth enhanced corporate value enabling us take challenge finding original approaches new healthcare practice truth needs topshare products pharmaceutical category pages japan outside japan business model centered total healthcare sustainable society share consumers experience provide variety sciencebased products services wes lo lc bi ea il n g using pocari sweat meet specific healthcare needs times community conceive products services physical mental wellbeing wellbeing contribute years time three areas pages physical social wellbeing solid financial foundation strong earnings power providing value drive sustainable growth bringing health people worldwide cultivating solid financial foundation strong earnings power whereby nutraceuticals iv solutions generate stable earnings act base therapeutic agents driver growth fund ongoing investment creative new areas befitting otsuka form basis sustained investment areas create new value face changing business environment pages unwavering quest originality aa rating pursue creativity implicit corporate philosophy across entire value chain research development business profit margin marketing ongoing challenge create innovative products services always thinking generate kind nutraceutical business innovation defines otsuka targeting unmet medical needs well yettobeimagined needs consumers inhouse drug discovery ratio ratio inhouse drug discovery project among latephase development projects december unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri development projects unmet needs number companies engaged iv solutions business many companies also export products neighboring countries thereby making meaningful contribution medical care countries psychiatry cardiovascular copyright iqvia created based annual category totals past years including iqvia midas otsuka research categories defined otsuka oncology neurology renal system reprinted permission january survey japan conducted otsuka projects projects project projects rating investment information inc average previous three years reference average operating profit margin sp food beverage select industry index constituents previous three years otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report value creation model inputs corporate philosophy sustainability mission value creation process outputs outcomes human capital human capital employees approx enhance employee engagement japan approx enhance measures respect human rights outside japan approx new technological revenue fiscal scientific developments new concepts billion hypotheses wealth technological relationship social capital scientific assets relationship social capital total group companies expand product access products services japan enhance system realization outside japan pharma pharmaceutical business healthful life business sites countriesregions ceuticals nutra therapeutic drugs clinical provide support covid pandemic chemicals ceuticals nutrition products diagnostics medical devices stakeholders manufactured capi ta l diversifying otc unique cosmedics created value nutraceutical business value provision manufactured capital manufacturing sites needs diverse products functional beverages functional consumers patients achieve stable supply highquality japan businesses services foods cosmedics otc drugs healthcare professionals products outside japan consumer clinical quasidrugs employees business promote sustainable procurement products nutrition partners investors consumer products business shareholders intellectual capital diagnostics dee vd icic ea sl beverages foods alcoholic local communities intellectual capital beverages society contribute solutions unmet needs research sites innovation japan businesses promote research development outside japan functional chemicals fine partnerships future health creating new value chemicals warehouse operations issues pioneering fields transportation packaging overlap derived businesses electronic equipment financial capital financial capital well niche fields maintain sound financial foundation total assets billion deliver stable returns shareholders total emissions fiscal sustainability mission co tons natural capital natural capital water energy consumption increase utilization renewable energy kl conduct water resource risk assessments water consumption strengthen environmental management compliance ryukan jissho sozosei godo december data companies including otsuka holdings subsidiaries affiliated companies manufacturing sites consolidated otsuka group otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report value creation process generates originality taking challenge impact value creation capital otsuka capital impact value creation fy progress related sdgs enhance employee engagement diversity promotion originality otsuka generated combination unique diverse businesses female manager ratio otsuka holdings first step otsuka groups value creation process approach envisions increased number employees taking parental leave total human capital male future order anticipate various needs healthcare aligned societys expectations enhance measures respect human rights try anticipate needs arise changing times environment ways formulated implemented otsuka group human rights policy people think health leveraging group strengths consisting unique march wideranging businesses combined human resources extensive knowledge expand product access experience formulate hypotheses combine new technologies scientific developments countries regions tuberculosis drug deltyba available accumulated ones create new value new products services launched adpkd drug jinarcjynarque countries also able create new value pioneering fields overlapped derived relationship regions various businesses way otsuka takes challenges create new value social capital enhanced system realization healthful life executed cooperation agreements prefectures japan possible total healthcare company promotion collaboration health awareness activities provide support covid pandemic donated relief goods funds achieve stable supply highquality products established began operation tokushima mima factory otsuka new technological pharmaceutical new manufacturing site daiya foods scientific developments manufactured new concepts promote sustainable procurement wealth technological capital revised otsuka group procurement policy september hypotheses established otsuka group sustainable procurement guidelines scientific assets september conducted supplier briefings suppliers contribute solutions unmet needs innovation new drugs launched pharma intellectual development projects unmet needs ceuticals research development expenses billion nutra capital inhouse drug discovery ratio chemicals ceuticals promote research development partnerships signed joint research agreements new partners unique otc cosmedics created value diversifying diverse maintain sound financial foundation products needs credit rating aa services businesses financial capital business profit billion record high since listing consumer clinical deliver stable returns shareholders products nutrition annual dividend per share medical diagnostics devices increase utilization renewable energy reduction co emissions adoption renewable energy tons natural capital conduct water resource risk assessments assessments conducted manufacturing sites companies strengthen environmental management compliance creating new value otsuka group acquired iso integrated certification future health issues pioneering fields scope companies otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka warehouse otsuka chemical otsuka foods otsuka pharmaceutical overlap derived development commercialization otsuka america pharmaceutical pharmavite otsuka holdings otsuka medical devices businesses cabpirin quick naviadeno ailamide viscoclear entrest inqovi quick navicovid ag enefluid injection unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri well niche fields ratio inhouse drug discovery project among latephase development projects strategic partnership taiho pharmaceutical astex pharmaceuticals msd joint research otsuka pharmaceutical axcelead drug discovery partners strategic partnership taiho pharmaceutical md anderson cancer center license agreement taiho pharmaceutical peptidream otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical including subsidiary okayama taiho pharmaceutical otsuka chemical otsuka foods otsuka holdings controlling company otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report description materiality description mtm plan longterm fy goals contribute unmet needs solutions otsuka 's business fully synchronized efforts address social issues grow achieve sustainability otsuka group 's approach sustainability guided corporate philosophy otsukapeople creating new products better health promoting business toward goals fiscal direction materiality worldwide otsuka group works contribute creation healthy sustainable mediumterm management plan fiscal society achieving growth pursue objectives supported comprehensive governance system determined material issues otsuka group society relationship materiality mediumterm management plan health people quality environment climate change resource recycling conservation water conservation governance announced goals pursued corporate philosophy entire group sustainability mission sustainability mission address social issues evolution toward healthier sustainable society simultaneously achieving growth activities supported challenge new frontiers promotion rd unmet needs address unmet needs psychiatry neurology areas comprehensive governance system otsuka create firstinclass products oncology cardiovascular renal area contribution sustainable society development projects generate innovation creative unmet needs diverse research platforms latephase development projects advancing next phase provide deltyba generic name delamanid eradication tuberculosis cumulative total cases supply deltyba pediatric patients society healthier society environment healthier planet launch clinical trial new treatment regimen health people quality climate change resource recycling conservation water conservation increase access deltyba collaborating partners governance creation system challenge new categories create new systems reinforce existing corporate governance compliance risk management realization new areas systems realizing healthy lifestyles healthful life create new concepts products keeping healthy life extension maintain highprofit structure process determining materiality material issues eye changes environments materiality initiatives otsuka focused issues discussed sustainability promotion determine otsuka group 's material issues first committee approved otsuka holdings board compiled list social issues referencing range directors meeting result material issues international guidelines frameworks including iso otsuka group determined society health people quality climate change resource recycling water conservation governance conservation gri un sdgs narrowed people quality environment climate change list issues evaluating terms resource recycling conservation water conservation importance taking account ability contribute governance relationship materiality capitals solution impact business strengths relationship capital human manufactured intellectual financial natural identification social issues reference respective international guidelines social materiality capital capital capital capital capital capital assessment social issues business activities contribute solving importance health society people determination material issues sustainability promotion committee viewpoint impact society otsuka group quality climate change approval otsuka holdings board directors meeting environment resource recycling conservation sustainability promotion committee promotes sustainability throughout otsuka group committee 's responsibilities include discussing deciding direction plans sustainability activities otsuka holdings director charge sustainability promotion serves committee chair committee members comprise group managers water conservation departments relating sustainability sustainability officers company governance visit otsuka holdings website map social issues httpswwwotsukacomencsrhdactivitymaterialityhtml otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report materiality material issues fiscal goals fiscal progress otsuka group determined material issues based importance society among social issues determined otsuka groups materiality selected nine issues groups businesses society health people quality environment climate regard especially important present set goals related fiscal change resource recycling conservation water conservation governance social materiality social issues goals activities related sdgs goals fy goals fy progress issues unmet medical contribution unmet promotion rd unmet contribute unmet promotion rd unmet needs areas unmet needs health needs needs solutions needs needs solutions address unmet needs psychiatry neurology areas new development projects projects create firstinclass products oncology area spread infectious eradication tuberculosis rd antituberculosis drugs latephase development projects projects diseases creation system improvement drug create firstinclass products cardiovascular renal area n utritional needs realization access areas unmet needs new development projects health ncreasing aging healthful life support awareness issues healthy life extension activities peoples health latephase development projects advancing next phase maintenanceimprovement mainly exercise eradication provide deltyba generic name delamanid eltyba nutrition etc tuberculosis cumulative total cases provided deltyba cumulative total cases promotion problem solving countriesregions supply deltyba pediatric patients strengthening partnerships acquired indication deltyba children europe october launch clinical trial new treatment regimen rpharm acquired marketing approval deltyba russia may p resenteeism creation corporate human resource development increase access deltyba collaborating implemented supply global drug facility gdf stop tb society unprepared culture stimulates diversity promotion partners partnership alliance partners healthier diversification creativity healthful management participated pantb collaboration accelerated society people enhance employee development new tb treatment regimen engagement continued participation global health innovative technology ghit fund creation system challenge new categories new areas increased supply plantbased food products starting operations new manufacturing site c onsumption gaining stakeholder trust sustainable procurement realization create new systems reinforce existing systems executed cooperation agreements prefectures production pursuing sustainability product design healthful life realizing healthy lifestyles promoted collaboration health fields impairs levels value chain thorough quality control create new concepts products keeping eye continued hold womens health seminars sustainability establishing quality stable supply changes environments c ut mh u lan tn iviv ee tr osa tary l oo af tth st ru ek ga th rae na tlt sh ac po pm roic x l imib ar ta er ly quality assurance system safety responsible promotional activities started healthy president service security information provision deepening communication creation corporate instill corporate culture philosophy c reu sm ouu rl ca et iv de e vt eo lt oa pl mpa er nti tc pp ra gt rs mn st h oe f oex te sucu kati v ge l oh bu l c ademy stakeholders culture stimulates build systems ongoing human resource oga promotion customercentric creativity development aligned changes society cumulative total participants health seminars approx management enhanced employee times engagement promote instill diversity source implemented health safety measures employees covid pandemic g lobal warming fy goal reduce co emissions innovation formulated otsuka group human rights policy climate reduction co throughout value chain emissions compared fy pursuing sustainability selfassessment questionnaire saq survey conducted cumulative total companies implementing saq change levels value companies companies participating supplier briefings stable supply products covid pandemic chain ustainable procurement held global production meetings environmental conducted supplier briefings suppliers management information exchange meetings environmental load fy goal reduce environmental original goal timescompanies fiscal held global product quality meetings increase reduction simple impact improving resource improved products based customer feedback environment resource incineration landfill efficiency recycling compared fy promotion business activities healthier higher content aimed sustainable state fy goal introduce renewable energy raise usage rate acquired iso integrated certification planet conservation r ac ty ecl iad l sa nd p ul ra pn et tb ba ose ttd l es society earth e sr ie od nu c ct oio mn p r ec cofree electricity e inx tp roa dn ud ce ed h coe gn etr ed ru atc oio nn yo sf ec mo af nr dee oel lae rc pr oic wity e r generation facilities switched supply green power office departments five group fy companies reducing fy goal understanding water resource fy goal strengthen cooperation reducing simple established otsuka group plastic policy water freshwater improvement water risks reduction simple incineration incineration landfill volume availability due use efficiency management effective landfill compared fy build internal group system improving conservation water resource risks compared fy use water resources higher content recycled usage rate recycled plantbased materials plantbased materials pet bottles f ragile governance longterm improvement strengthen corporate system corporate value governance fy goal improve water use efficiency accordance carried water resource risk assessments using aqueduct social change risk thorough compliance improvement water use efficiency water resource risks unevenly distributed formulated water resource risk analysis charts manufacturing governance risk identification evaluation compared fy countryregion site identified watershed issues around sites management promotion rd build system strengthen compliance within group ntroduced enterprise risk management july unmet needs strengthen corporate governance raise effectiveness c arried activities directors raise effectiveness situation productivity go due poor condition mind body despite coming work b uild governance system capable global business b oard directors meeting attendance rate development response various changes mplemented otsuka group global policy conflict interest unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri cumulative total since tsuka advanced training healthy aging supporters program supports pharmacies health information hubs strong connections local communities december including carbonneutral electricity water resource risk assessment tool developed world resources institute otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report sustainable society feature toward realizing sustainable society unique total healthcare company social physical mental social wellbeing wellbeing given climate change becoming major social issue otsuka group developing marketed nutritional foods longterm view earths health soybeans part japan 's traditional food culture referred otsuka group operates diverse healthcare businesses centered pharmaceutical business physical mental meat fields welcomed daiya foods nutraceutical business combination diverse businesses enables us produce wellbeing wellbeing canada otsuka group accelerating creative products value able contribute peoples health worldwide marketing plantbased food products global basis total healthcare otsuka deliver feature describe otsuka combining new technologies knowhow acquired group creates value combination diverse businesses process groups diverse businesses providing new value addresses various social needs supported revenue structure governance daiya otsukas soylution daiya foods website httpswwwotsukacojpennutraceuticalabout httpsdaiyafoodscomwhoweare soylutionabout pharmaceutical business provide comprehensive creative product marketing value creation solutions healthcare issues promote various innovative initiatives combine expertise experience combination diverse businesses psychiatry neurology cuttingedge digital technologies abilify mycite worlds first digital medicine facilitates monitoring drug adherence important us adapt change needs times entails ongoing focus behavior patients expands available options issues relating changes social environment including lifestyle changes superaging suitable therapies lead improved communication societies unforeseen major disasters spread infectious diseases need among patients caregivers healthcare professionals environmental conservation otsuka group provides continuous support address various health psychiatry area text information makes medical issues social needs leveraging strengths total healthcare company records otsuka pharmaceutical ibm japan jointly developed mentat electronic medical record analysis delivering innovative products synergy continue develop sciencebased products saga solution analyzes text information using text mining effects nutraceuticals research institute conduct research technology support identification optimal approaches relationship soybean isoflavones womens health patients otsuka group continues take technologies expertise accumulated iv solutions addition research exercise nutrition particularly challenge developing new medical solutions aiming clinical nutrition product businesses since basis focused equol ingredient produced daidzein improve quality life patients relieve burden placed many innovative products developed date metabolized intestinal bacteria used develop others facilitate recovery enhance communication example development pocari sweat inspired equelle dietary supplement supports womens health psychiatry area drug adherence management idea drinkable iv solution could easily replenish beauty otsu nutraceuticals research institute conduct repeated relapse rehospitalization among many fluids electrolytes lost body similarly development research theme intestines nutrition led issues faced calorie mate inspired concentrated liquid food regimens development bodymaint utilizes plantderived life expectancy extending globally one two people conceived nutritional food product could lactic acid bacteria b evidencebased efficacy health born developed world live past age alternative iv solutions rd projects leveraged management era year lifespan call mental social knowledge production expertise related groups clinical wellbeing addition physical wellbeing social nutrition products turn led development equelle bodymaint environments lifestyles become increasingly diverse unprecedented sciencebased products worlds first otsuka group address various issues improve three forms commercial retort pouch food product bon curry also wellbeing realize sustainable society developed applying sterilizationrelated technology electronic medical records psychiatry contain free descriptions various expertise accumulated production iv solutions information difficult quantify eg medical history symptoms information text mentat electronic medical nutraceutical business established japans first record analysis solution uses natural language processing technology private research institute clinical exercise nutrition organize analyze electronic medical records psychiatry previously hinexr concentrated considered difficult aggregate database presents information liquid food form useful medical settings hospital management forerunner calorie mate otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report feature unique total healthcare company business structure achieving sustainable governance system global portfolio human resources familiar variety industries markets management appointed outside directors bring thirdparty enhancement corporate value viewpoint operations board directors composition board directors otsuka holdings global business support department established includes multiple executive directors serve concurrently strengthen monitoring operating companies otsuka group 's diverse business operations play important role sustainable growth management teams operating companies board executive director charge business portfolio management including necessary respond changes business environment section promotes optimal groupwide investment strategies describe analyze risks opportunities perspective business structure corporate strategies aimed maximizing synergy underpinned corporate governance pages rapid relay information closeknit cooperation diverse discussion corporate governance pages sustainable enhance corporate value total healthcare company history building revenue foundation diverse business foundation enables cooperation local communities diverse businesses adaptation various environmental changes since foundation otsuka group developed innovative pharmaceutical business nutraceutical business otsuka group promoting communitybased health maintenance improvement initiatives products ahead times lead resolution social substantially different business characteristics achieved well disaster prevention relief activities describe activities supporting peoples issues relating healthcare continued grow sustainable growth respectively diversifying various risks health possible otsuka total healthcare company diversifying businesses business diversity turn supported business environment example pharmaceutical sustainable growth making groups revenue structure business medical expenses drug prices reduced getting closer consumers delivering business nutraceutical business disaster prevention resilient risks ready act opportunities however regarded opportunities lead new value response provided local support closely aligned consumer otsuka group launched pocari sweat main advancement health awareness dissemination nutraceutical business applying knowledge needs total healthcare company revenue source nutraceutical business addition selfmedication multifaceted business platforms expertise accumulated products including healthcare needs vary substantially depending individual 's providing pharmaceutical information medical representatives ideas unique total healthcare company enables us topics health promotion prevention lifestylerelated circumstances well time region furthermore days cooperated group crossbusiness activities adapt rapid changes business environment take diseases dietary education sports promotion disaster global covid pandemic substantially transformed promoting installation vending machines medical various challenges envisioning future countermeasures promote contribution local communities people 's lifestyles institutions revenues earned nutraceutical opportunities risks pharmaceutical business concluded health cooperation agreements expected health issues business invested research development opportunities risks nutraceutical business prefectures japan agreements implement social issues become pharmaceutical business tireless research development developed abilify antipsychotic launched revenue performance awareness activities health promotion provide speakers increasingly diverse lectures supply relief goods event emergency complex otsuka group products contributed better health nutraceutical consumer products businesses worldwide way pharmaceutical business become billion pharmaceutical business disaster recent years also provided new specialized continue information concerning pharmaceutical business addition development main revenue driver otsuka group nutraceutical preventive health information focused nutrition exercise futureoriented value business also developed many longselling brands recuperation provide support total healthcare creation focus continuously achieving business profit margin higher company disease awareness activities helping diverse businesses thereby iv solutions business engaged since healthy people stay healthy body mind present enhancing longterm soon founding maintains leading share mental care needs increasing also plan support corporate value based japan supports sustainable growth group mental health people local communities leveraging provision total stable revenue base support municipalities strengths psychiatry neurology area healthcare making market defined otsuka copyright iqvia created based mat covid pandemic photo provided december jpm reprinted permission addition combined initiatives pharmaceutical social contribution suginamiku interbusiness communication governance working resolve diversifying health issues consumers diversity source new ideas innovations maintaining consistency direction nutraceutical business continuously carried health awareness activities overall business management across different market environments cultures viewpoints values leveraging assets acquire rd identifying health key issue otsuka group operates global portfolio management structure otsuka issues dialog local residents continue relationships support holdings core governance structure disseminates corporate philosophy resolving issues cooperation local communities based relationships trust essence management ensuring close interbusiness communication view creating established concluded cooperation agreements synergistic value diverse businesses prefectures japan new initiatives complement partnerships naoshi sato expert strengths pharmaceutical business help resolve increasingly dissemination corporate philosophy senior vice president diverse consumer health issues era year life span sense philosophy business practice employee across associate general manager essence management able identify social issues health issues including information world time executive management sends nutraceuticals division director societal health provide provide important adapting continually otsuka group pursues corporate philosophy otsuka proactive messages concerning corporate philosophy relations department changing healthcare environment providing optimal solutions people creating new products better health worldwide essence management handed director promotion advertisement department continuously implement various educational activities order historical management executives otsuka pharmaceutical promote understanding dissemination corporate message president pages otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report message cfo framework financial strategies market complement cash earned global practice business management products cash invested sustainable rd aimed awareness capital cost pursue sustainable returns excess cost capital strengthening products pipeline psychiatry neurology oncology cardiovascular renal areas growth enhanced corporate value roic wacc investments targeted creating new value answer unmet maximizing business value making growth medical needs including diseases existing therapeutic cash flow generation cash allocation drugs new concepts integrate drugs digital investments technologies abilify mycite medical devices business growth apply new approaches ultrasound renal denervation profit operating investments reinvestment treatment cash flows yuko makino improvement capital refining manufacturing technologies enhancing product executive director cfo ccc expenditure quality implementing rationalization measures iv solutions otsuka holdings co ltd reduction business achieved stable cash creation japanese market nonoperating assets dividends shareholder link development overseas growth markets returns debt financing share buybacks reinvesting reallocating funds among business areas well regional markets nutraceutical business earn stable cash progress third mediumterm overview attributable covid pandemic however increased debt capacity major brands whose markets mature reallocate funds plan revenue global products abilify maintena rexulti optimal capital structure creating new categories developing new regions build overview plan samscajinarcjynarque lonsurf driven business brands strengthen manufacturing marketing structures performance leading progress ahead plan third mediumterm management plan positioned cash conversion cycle nurture brands making proactive investments continue working achieve plans targets advance global market unique total healthcare promoting value products various measures adapted new normal company fiveyear growth phase provider total healthcare solutions daily health pursuing challenging targets major brands pharmaceutical business nutraceutical business maintenance promotion diagnosis treatment pocari sweat nutrition sante brand nature made maximizing existing business value roic maximize existing business value create new value diseases otsuka group emphasizes social contribution nurture brands bodymaint equelle daiya management well conduct business management corporate innovation always ready take challenges nutraceutical business fiscal line heightened wide awareness capital cost thereby maintain sustainable second mediumterm management plan investments aligned corporate philosophy health awareness mainly regard disease prevention growth making growth investments ensuring returns advanced diversification revenue structure order help us enhance corporate value social brands nutraceutical business favorably received shareholders counteract patent expiration abilify led contribution many consumers selecting nature made daiya products business profit fiscal set record high since principle growth investments funded particular revenue daiya plantbased food products business progress listing first section tokyo stock exchange reinvestment cash returns businesses increasing faster market growth performance targets pharmaceutical business five nutraceutical business involves diverse products business performance recovered level patent stable cash supply structure established within otsuka year period third mediumterm management plan set business fields makes adaptable rapid changes expiration since however factors relating covid group centering europe north america japan make increasing revenue billion yen global products external environment contributes stable business operations pandemic including people staying home certain decisions based achieving optimal capital structure without billion yen new products scheduled medium long term impact performance viewpoint business overreliance particular source funding taking launch plan calls revenue billion yen continuity situation renewed appreciation consideration business risks credit ratings expected rate return final fiscal year plan middle year fiscal third importance diversity business portfolio combines among investors factors secured diverse fiscal iv solutions certain therapeutic drugs mediumterm management plan pharmaceutical business nutraceutical business funding means case impact covid pandemic affected reduced visits medical institutions fewer surgical mitigating business risks emergency situations able prolonged including issuance corporate bonds commercial operations lower hospital bed occupancy factors fiscal middle year third mediumterm make investments sustainable growth paper funding financial institutions commitment management plan plan achieve revenue year set standard groupwide roic least lines billion yen revised downward initial cost capital addition measures corporate department supports cost efficiency third mediumterm management plan target billion yen maximizing business returns reviewing improving smooth business operations establishing groupwide business plan achieve business profit billion yen revised business asset efficiency set kpis according business foundation specific activities include promoting business fy upward initial target based growth characteristics furthermore introducing incentives linked cost efficiency expanding shared services establishing br uev sie nn eu sse profi b bi il li io n average annual growth rate fh b e eg nlo mba al k p inro gd su tec ats n pd r ot gh e n ssu traceutical business h rb ou us gin os us p ther ef gr rm oua pn c e th ew ree b yr e xs mill ii zn ig n gr exic ist ina gn ba ug se inm ee sn v alue cn ef nra test rr inu gct ou nre j f ao pr n n nm sn tau nfa dc ru dr ii zn ing g pp uer ra chti ao sn ins go f th ne g nr oup roe higher measures enhancing corporate value framework financial strategies support new pra mu ofa tec stu ar sin seg ee ffp ica ir et nm ce yn bt ys rt eh vie e wco inrp go cr ra ote ss se hp aa rr et hm oe ldn n gl ss w hich billion achieve goals third mediumterm management value creation held accordance japans corporate governance code plan maximizing existing business value creating new value third mediumterm management plan aim utilizing selling idle assets consider important strike balance organic maximize returns cash basis optimize allocation basic policy shareholder returns maintain stable growth existing businesses sustainable investment new investment focus balance sheet dividends emphasizing continuity stability hig h er oorr hhiigghheerr v wa il du ee ac wre aa rt eio nn e sin os ft il cli pg b alu cs oin se ts h roa un ga hg oe um e thn et w oi tt sh u ka c go rr op uo pra te mtr ae nn ag gt eh men ei nn tg p enro ad bu lic nt g l ufe sc ty oc l le k da ig vee rm sie fin et pn rd fb itu ss tin rue cs ts u p reo r tt ofo lio di ev pid ee nn dd ins g w oe n w pril ol fc ito n gs roid wer ha ad pit pio lyn ina gl ah cr oe mho pl rd ee hr e r ne st iu vern p proach enable us maximize cash returns existing businesses new growth investments securing sufficient cash returns pursue growth investments allocate funds growth investments strengthen financial pharmaceutical business key strategies solid financial standing optimal capital structure foundation thereby allowing stable ongoing shareholder regard cash allocation first generate additional coming years continue pursue business return returns cash cost optimization controlling ratio selling capital efficiency promoting measures business management e e general administrative expenses products already corporatewide awareness capital cost revenue business profit average annual growth rate roe announced may otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report grow details healthrelated initiatives visit advancing unique total httpswwwotsukacomencsrsocietyhealth healthcare company among otsuka groups materialities set specific goals three healthrelated social otsuka group 's operations encompass two core businesses pharmaceutical business issues unmet medical health needs spread infectious diseases nutritional needs provides comprehensive health support diagnosis treatment diseases third mediumterm management plan ending fiscal measures nutraceutical business contributes maintaining improving health healthy taken toward resolution people going beyond boundaries conventional pharmaceutical company aim indispensable contributor peoples health worldwide leveraging strengths unique social issue unmet medical health needs total healthcare company goal contribute resolution unmet needs business strategy existing business value maximization new value creation fy goals fy progress strengthen strategic initiatives growth drivers four global products pharmaceutical business promotion rd unmet needs areas unmet needs three major brands three nurture brands nutraceutical business address unmet needs psychiatry neurology areas new development projects projects create firstinclass products oncology area latephase development projects projects launch nurture new drivers sustainable growth pharmaceutical nutraceutical businesses create firstinclass products cardiovascular renal area areas unmet needs performance target business profit cagr new development projects latephase development projects advancing next phase organic growth mainstay products brands pharmaceutical nutraceutical businesses actively invest rd continue creating new drugs drive revenue beyond next unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri mediumterm management plan cumulative total since revenue billion third mediumterm social issue spread infectious diseases management plan targets business profit billion cagr fy goal eradication tuberculosis roe higher fy goals fy progress p rovide deltyba generic name delamanid deltyba progress third mediumterm revenue business segment cases provided deltyba cases countries management plan fy upply deltyba pediatric patients regions launch clinical trial new treatment regimen acquired indication deltyba children europe overview fiscal increase access deltyba collaborating partners october rpharm acquired marketing approval deltyba russia fiscal second year third mediumterm management may plan though covid pandemic certain impact took implemented supply global drug facility gdf pharmaceutical business stop tb partnership alliance partners heightened health awareness growth opportunity leveraging nutraceutical business participated pantb collaboration accelerated consumer business true value unique total healthcare company achieved billion yen development new tb treatment regimen businesses continued participation global health innovative technology revenue billion yen increase previous fund ghit fund year maintaining solid growth furthermore business profit billion yen increase previous year setting record high since stock listing social issue nutritional needs goal creation system realization healthful life third mediumterm management plan progress date announcement may fy goals fy progress cagr billion e e challenge new categories new areas increased supply plantbased food products create new systems reinforce existing systems realizing starting operations new manufacturing site revenue healthy lifestyles executed cooperation agreements prefectures japan create new concepts products keeping eye changes promoted collaboration health fields business profit rd environments continued hold womens health seminars expenses th anniversary otsuka health comic library rd expenses cumulative total oathas registrants approximately launched kenko shacho healthy president service business profit roe higher higher otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report contributed resolving unmet needs following approval lonsurf pharmaceutical business additional indicational syndrome inappropriate trifluridinetipiracil anticancer agent antidiuretic hormone secretion siadh june backed strengthened information provision treatment third mediumterm management plan calls us progress four global products may jynarque launched us option unresectable advanced recurrent colorectal cancer maximize existing business value create new value four global products expanded regions added treatment adpkd efforts raise disease awareness approval additional indication unresectable challenge new frontiers otsuka indications overseas worked increase awareness make clinical trial data available helped spread recognition advanced recurrent gastric cancer japan us europe generate innovation creative diverse research convenient dosage formulations drugs revenue fiscal disease drug leading steady increase prescriptions lonsurf increasing us platforms take advantage strategic framework rose previous year making considerable prescriptions europe also jinarc sold approximately particular home treatment use oral anticancer position four global productsabilify maintena rexulti contribution growth consolidated performance countries number patients receiving treatment agent recommended given covid pandemic samscajinarcjynarque lonsurfas growth drivers drug increase lonsurf selected one oral therapy accelerate growth targeting increase revenue revenue plan four global products new products maximize value currently pursuing promotion lines fiscal billion yen global products well billion four global products new products therapy clinical studies treatment combinations billion yen new products scheduled launched e current mediumterm management plan billion otsuka group focuses unmet medical health needs social issue end fiscal began eight new b il li n growing north american oncology business development projects next phase unmet needs areas approx taiho oncology strong year despite covid pandemic lonsurf sales grew nine projects since fiscal advanced three latephase billion significantly metastatic colorectal cancer mcrc metastatic gastric cancer pandemic development projects next phase nine projects since fiscal helped reveal value oral therapies treatment options cancer patients also taiho unmet needs areas oncology launched inqovi market myelodysplastic syndromes multi aaa e e e e e e e e product commercial organization focused solid liquid tumors unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri rd mtm plan th mtm plan remainder mediumterm plan planning continued growth north timothy whitten america based following potential lonsurf growth clinical trial lifecycle management plan studying lonsurf treatment combinations earlier course mcrc fy taiho oncology inc billion fy revenue yearonyear revenue plan growth rate president ceo completing initial inqovi launch potentially commercializing new compounds originating inhouse discovery programs aggressively looking external neartomarket inlicensing abilify maintena opportunities rexulti additionally development organization continues plan implement clinical trials focused exciting compounds originating tsukuba research center samscajinarcjynarque lonsurf total deltyba abilify maintena samscajinarcjynarque otsuka group considers spread infectious diseases social issue targets eradication tuberculosis tb aripiprazole antipsychotic longacting injectable tolvaptan vreceptor antagonist one infectious diseases largest death toll present day ten million people develop tb approx million die tb annually culmination years rd otsuka group developed deltyba one global treatment schizophrenia increased samsca highly evaluated various guidelines japan worlds first new tb drugs half century december available countriesregions awareness drugs efficacy claims convenient dosage prescriptions increasing treatment cardiac edema important option patients multidrugresistant tb october approved additional pediatric formulation following us approval japanese hepatic edema prescriptions treatment autosomal indication europe eradicating tuberculosis still major challenge worldwide support effort otsuka approval additional indication treatment dominant polycystic kidney disease adpkd intractable renal working expand access deltyba since shipped enough doses treat cases bipolar disorder prescriptions increasing disease increasing owing promotion proper use guidelines disease awareness activities drug also rexulti supply stop tb partnerships gdf since february brexpiprazole atypical antipsychotic global operation adpkd drug participation access programs implemented countries public international organizations endtb program conducted united global health agency marketed adjuvant treatment major depressive disorder treatment schizophrenia us drug highly access programs implemented governments south africa india evaluated efficacy safety new treatment option access alliance partners diseases japan drug marketed treatment alliance rpharm jsc russia cis etc schizophrenia prescriptions grown significantly europe launched approx contributed approx alliance mylan nv viatris inc india south africa highburden countries sales began april countries patients access compassionate use program present several clinical trials way aim supplied patients countries contributing treating unmet needs psychiatry contributed approx neurology area patients public programs provides exceptional access yettobeapproved drugs details tb initiatives visit exceptional basis patients serious lifethreatening diseases ghosh et al eur respir j nov httpswwwotsukacomencsrsocietyhealth estimated number adpkd patients pharmaceuticalhtml us europe japan march inhouse survey otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report future pharmaceutical business opportunities risks implemented response medical cost inflation agitation associated dementia alzheimers type risks affect environment surrounding pharmaceutical become serious issue worldwide despite risks otsuka estimated approximately million people estimated us alzheimers disease thought business operating include relating reduced visits group developing multiple pipelines multiple areas order large number patients exhibit form behavioral disorder agitation excessive motor activity medical institutions delayed clinical development due contribute resolution social issues initiatives verbal physical aggression kind disorder places burden patients caregivers impacting quality life global covid pandemic intensifying competition paradigm targeting diseases high unmet needs otsuka group aims market worlds first treatment agitation associated dementia alzheimers type clinical shifts treatment due technological innovation policies trials way two drugs different mechanisms action brexpiprazole rexulti avp hope therapeutic development projects contribute physical wellbeing patients strengths weaknesses also mental wellbeing social wellbeing including caregivers become solution realization providing total healthcare solutions diagnosis treatment management personnel advanced skills diversifying sustainable society global rd marketing assets psychiatry neurology businesses drdecision resources llc rights reserved reproduction distribution transmission publication prohibited area cardiovascular renal area strengthening portfolio management related patent expiration presence oncology area mainstay products w stable profit iv solutions business trength eakness originality free fixed ideas opportunities threats advances science technology progress basic global drug price control policies promotion generic drug research related diseases use due medical cost inflation status psychiatry neurology pipelines creation synergies therapeutic drugs advances intensifying competition core areas march digital technologies restrictions sales promotion activities due stricter regulations country development promotion precision mediciones penha pnce eff rica tcy unity pandemic related spread infectious diset aseshreat pipeline features indication region status brexpiprazole dopamine partial major depressive disorder japaneurope phase iii agonist schizophrenia china phase iii agitation associated japanus future initiatives focus psychiatry neurology oncology phase iii dementia alzheimers type europe pharmaceutical business promoting various measures cardiovascular renal areas satisfaction current posttraumatic stress disorder us phase iii toward resolution issues taking challenges treatment methods many diseases remains low aim new areas otsuka resolving unmet needs create innovative new drugs unique approaches borderline personality disorder us phase ii generating innovations based creative diverse research leverage synergy diverse businesses schizophrenia longacting us phase injectable platforms aripiprazole dopamine partial bipolar disorder japan approved longacting injectable agonist schizophrenia china filed opc serotonin major depressive disorder psychiatry neurology norepinephrine japan phase ii dopamine reuptake aiming become topclass global player psychiatry neurology area inhibitor highpotential pipeline product portfolio avp nmda receptor agitation associated useurope phase iii antagonist serotonin dementia alzheimers type psychiatric diseases schizophrenia bipolar disorder treatments yet established norepinephrine reuptake inhibitor negative symptoms us phase iiiii major depressive disorder develop age affect causes mechanisms fully understood makes sigma receptor schizophrenia persons social life career studies moreover discovery new drugs extremely difficult otsuka group agonist traumatic brain injury us phase ii concerns increase alzheimer 's disease world entered psychiatry neurology area intermittent explosive disorder us phase ii population ages diseases affect patients continued take challenge new drug discovery quality life also place strain family members goal contributing medical needs centanafadine norepinephrine attention deficit hyperactivity dopamine disorder caregivers well healthcare economy still highpotential pipeline product lineup us phase iii serotonin reuptake many psychiatric neurological diseases satisfactory aim become topclass global player area inhibitor pizuglanstat pgd synthase inhibitor duchenne muscular dystrophy japan phase iii fremanezumab anticgrp antibody migraine japan filed opc epilepsy us phase development projects unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri project advanced fiscal approved september brand name abilify prolonged release aqueous suspension im injection otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report oncology status oncology pipelines march maximizing business value proprietary drug discovery platforms initiatives new development pipeline features indication countryregion drug discovery technologies methodologies status us approved taiho pharmaceutical broad portfolio supported meanwhile centering external collaborations otsuka myelodysplastic syndromes proprietary drug discovery platform technologies including pharmaceutical taking challenge establishing new japan phase astx dna methyltransferase inhibitor proprietary biochemical modulation technology uniquely developed therapies focus future includes creating synergies europe phase iii history well cysteinomix drug discovery technology new modalities areas genemodified cell therapies acute myeloid leukemia us phase enabling specific covalent modification therapeutic targets individual group companies combining accumulated fragmentbased drug discovery technology established astex assets fields strengths bolster global operations solid tumors lymphomas us phase ii tolinapant iap inhibitor pharmaceuticals company also accelerating development enhance business value tcell lymphoma japan phase drugs resolve unmet needs working pharmaceutical platform discovering compounds cause specifically covalent bonding tolinapant iap inhibitior dna collaborators furthermore looks opportunities reactive amino acid residues mainly cysteine residues protein potential acute myeloid leukemia us phase astx methyltransferase inhibitor drug target proteins collaboration promising startups corporate venture technology create new compounds molecular design clarifies astx erk inhibitor solid tumors us phase iii capitals thereby expanding development pipelines cancer interactions smallmolecular fragments showing pharmacological activity immunotherapy areas acquiring innovative drug measured highthroughput screening large molecule proteins astx mdm inhibitor solid tumors us phase iii complicated structures implicated diseases discovery platform technologies potential drug targets astx dna methyltransferase inhibitor myelodysplastic syndromes japanus phase cardiovascular renal system chronic myeloid leukemia ponatinib bcrabl tyrosine kinase inhibitor china phase ii acute lymphoblastic leukemia creating firstinclass products new drug discovery technologies medical devices diffuse large bcell lymphoma japan phase cardiovascular renal area addition strengthening unique medical devices drawing innovative technology opb hematological cancers us phase proprietary drug discovery platforms also plan actively strengths drugs clinical research ultrasound renal make growth investments examples included denervation treatment new therapy expected decrease opb solid tumors japan phase business alliances akebia therapeutics vadadustat high blood pressure cases effectively treated japanus tas dutpase inhibitor nonsmall cell lung cancer phase ii aurinia pharmaceuticals voclosporin acquisition existing drugs ultrasound renal denervation system europe visterra company renal diseaserelated pipeline breakthrough device designation us fda osteosarcoma japan phase iii otsuka group also strive find solutions unmet needs aiming create firstinclass products new drug pamufetinib multikinase inhibitor prostate cancer japan phase ii resolved drugs advancing development discovery technologies medical devices gastrointestinal stromal tumor japan phase iii pimitespib hsp inhibitor solid tumors useurope phase strengths drug discovery otsuka pharmaceutical tas solid tumors japan phase otsuka pharmaceutical global satellite research structure sites japan uk japanus cholangiocarcinoma phase iii europe us china thereby pursuing drug discovery diverse modalities including small molecular drugs antibodies cell gene therapies company 's smallmolecular drug breast cancer useurope phase ii futibatinib fgfr inhibitor discovery platforms created firstinclass drugs central nervous system cardiovascular japanus fgfr aberrations cancers phase ii system renal areas addition astex uk acquired approval several new europe oncology drugs fragmentbased drug discovery based protein structural analysis urothelial cancer useurope phase ii toshiki sudo computational chemistry visterra us engaged antibody drug discovery based tas peptide vaccine urothelial cancer japan phase ii executive director proprietary antibody preparation technology otsuka pharmaceutical aims contribute research intellectual global healthcare creating innovative drugs open innovations academia tas prostate cancer useurope phase property biotech outside japan tas solid tumors useurope phase iii otsuka pharmaceutical tas solid tumors useurope phase status cardiovascular renal pipelines tas lsd inhibitor acute myeloid leukemia us phase march tas solid tumors japan phase iii development pipeline features indication countryregion status tas acute myeloid leukemia us phase syndrome inappropriate trabectedin tolvaptan vreceptor antagonist antidiuretic hormone secretion japan approved yondelis ovarian cancer japan phase opc vreceptor antagonist cardiac edema japan filed canerpaturev oncolytic virus pancreatic cancer japan phase us filed tbi nyeso sitcr gene therapies synovial sarcoma japan phase iii vadadustat hifprolyl hydroxylase inhibitor renal anemia europe phase iii tbi cd car gene therapies acute lymphoblastic leukemia japan phase iii vis antiapril monoclonal iga nephropathy japanuseurope phase ii chemotherapyinduced nausea ultrasound renal cauterization renal sympathetic fosnetupitant nk receptor antagonist vomiting japan filed high blood pressure japanuseurope denervation system nerves medical device development projects unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri development projects unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri project advanced fiscal project advanced fiscal approved july brand name inqovi approved june brand name samsca otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report nature made nutraceutical business pharmavite leading company us supplement us retail multi leading sales share vitamin sales choice industry nature made supplement brand pharmavite japan us third mediumterm management plan calls revenue revenue plan three major brands three nurture brands pharmacists develops markets products free flavorings colorings growth billion yen three major brandspocari billion three major brands three nurture brands preservatives lineup highquality supplements sweat nature made nsand billion yen three key items verified meeting strict e nurture brandsbodymaint equelle daiya billion quality criteria set united states pharmacopeia usp b ased total us retail sales aggregate data reported furthermore working maintain highprofit nature made leading choice us pharmacists scantrack service supplement vitamin category week period ended december information resources inc structure capable sustained business profit margin ap p ro x billion selfmedication increasingly prevalent us ntage sri health food multivitamin market cumulative market share higher creating new product concepts anticipation billion recent years related demand continued increase driven brand januarydecember changes business landscapes expanding factors include medical cost inflation us supplement us news world report pharmacy times survey product categories letter vitamins ae coenzyme q omegafish oil new categories new regions market continues grow cagr flax seed oil herbal supplements mood health supplements diabetic sales substantially increased multivitamins cholesterol managementnatural garlic supplements due heightened health awareness aaa e e e e e e e e rd mtm plan th mtm plan mainly regard disease prevention yoy change nature made revenue covid pandemic aim turn nature made billion rd mtm plan yen brand developing products billion business profit left new products global new businesses business profit margin incorporate cuttingedge science operations taking challenges new categories euromonitor international uk business profit margin nutrition sant ns maintain higher organic food market europe grown recent first half second half first half second half years healthconscious consumers demand safer trustworthy foods trends freefrom foods build resilient business foundation health foods products countries nurture brands alternative products attracting attention millennial around world centered europe generation others fiscal european meatfree manufacturing sites ns obtained iso iso food market worth approximately billion us dollars nd mtm plan major brands grown rapidly past five years cagr well ifs certification international standard review management assets auditing food manufactures conducts production glutenfree food market worth around underpin value chain concern environment high level quality billion us dollars e e management ns built new factory glutenfree expanding cagr products france strengthened development free products meet evolving consumer needs ns health progress three major brands sports beverage market asiapacific nutritional food food products free specific ingredients foods contain gluten pocari sweat us million referred glutenfree products company provides euromonitor international uk retail value rsp overseas mainly asia sales volume pocari sweat beverage replenishing fluids electrolytes increasing due awareness activities tailored characteristics needs region cagr asiapacific sports beverage market excluding japan pharmavite transformation continues th anniversary year period intend outpace recent market growth forecasting cagr overseas revenue pharmavite continuing build future ahead mediumterm pocari sweat period third mediumterm china indonesia thailand philippines vietnam management plan transformation accelerates shifting toward new ways management plan hong kong myanmar others business model mindset staying true foundational values rooted science furthermore given higher levels health consciousness euromonitor international uk excluding japan quality means business model transitioning historically retailfocused company strengthening global sales structure expand leveraging science unique moment consumers focused new regions expect growth demand health proactive maintenance health wellness pharmavite seeking meet need beverages pocari sweat jeff boutelle leveraging science technology innovation leader preventative solutions future aim grow pocari sweat overseas revenue plan ceo pharmavite llc occasion pharmavites th anniversary reflect back founders philosophy billionyen brand enhancing brand strength nutrition basis proactive maintenance health wellness focusing cagr original marketing thoroughly communicates future bringing gift health life nature made megafood equelle product concept nurish nature made brands euromonitor international uk otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report progress three nurture brands future nutraceutical business bodymaint opportunities risks issues utilizing expertise honed pharmaceutical business bodymaint commercialized based research conducted nutraceutical business involves risks stagnation otsuka group develop original sciencebased products otsuka pharmaceutical themes intestines global economy due covid pandemic intensifying support persons aspirations live healthy life nutrition exercise nutrition contains b competition diminishing market japan due population continue identify underlying health needs examining proprietary lactic acid bacteria focusing health management decline sluggish markets due unseasonable weather social issues develop business focus functional athletes exposed risks related intense training despite risks pursue solutions emerging health beverages functional food products resolve needs developed bodymaint jelly conditioning food support many athletes sports trainers plantderived lactic acid bacteria b also developed bodymaint drink conditioning beverage lactobacillus pentosus onricb plantderived lactic strengths weaknesses containing b help replenish fluids electrolytes acid bacteria isolated fermentation type support proper hydration bodymaint drink expands value tea leaf traditionally consumed northern thailand creative products marketing based scientific evidence management personnel advanced skills diversifying isolated sanae okada professor emeritus tokyo university pocari sweat products longterm popularity businesses product line supporting health management agriculture efficacy confirmed otsuka overseas businesses incorporate solutions social issues brand development field takes time consumers pharmaceutical core business processes j gen appl microbiol w steady earnings power trength eakness equelle equelle originated research conducted otsuka opportunities threats pharmaceuticals saga nutraceuticals research institute rising consumer awareness selfmedication prevention daily sluggish overall beverage market due unseasonal weather womens health research theme equelle contains female hormone health tandem medical cost inflation intensification competition core areas due entry new equol sold japan us food product estrogen diversification diet competitors supports womens health beauty time aging pandemic related spread infectious diseases brings physical mental changes japan deployed pportunity hreat equol dedicated staff expert knowledge womens health nationwide cooperation physicians pharmacists equol healthcare professionals convey importance equol ingredient produced daidzein soybean personal care women experiencing physical isoflavone metabolized intestinal bacteria one aspect mental changes among activities aimed maintaining otsuka pharmaceuticals many years soybean research future initiatives goal develop provide world creative products improving health women enhancing quality life focus properties equol saga nutraceuticals rd site nutraceutical business investigate themes maintain improve peoples health backed scientific research institute succeeded isolating lactococcus otsuka pharmaceutical provides broad range information strain lactic acid bacteria produces equol publicize nutrition exercise unique viewpoints evidence concerning nutrition womens health website progress results variety research continue utilize expertise honed pharmaceutical business leader global research field media daiya daiya foods develops manufactures sells highquality saga nutraceuticals research institute creative plantbased food products cheese alternatives since establishment japans first private research dressings desserts brand daiya enjoyed institute clinical exercise nutrition saga nutraceuticals vegetarians people food allergies also health research institute conducted rd various fields related conscious millennial generation us plantbased alternatives market continues grow exercise nutrition womens health health issues daiya foods expanding sales channels product lineup one largest controlledenvironment rooms japan mainly area cheese alternatives core completed institute enabling recreation hypoxic product third mediumterm management plan environments equivalent found altitude plan achieve revenue cagr meters previously difficult recreate well hightemperaturehighhumidity lowtemperature lowhumidity conditions facility helps advance research percentage people bought plantbased foods sports nutrition verifying effects fluid environmental concerns nutritional intake environments h ttpswwwfoodnavigatorusacom pts articleshifthoware consumersthinkingaboutplantbased eatingmattsonunveilsnewsurveydata otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report otsu nutraceuticals research institute creation system realization healthful life otsu nutraceuticals research institute established otsuka group focuses nutritional needs social issue pursues creation system advance research intestinal immunity particular realization healthful life focus intestines play key role overall health one example institutes research related enhancing bodys biological barrier increasing secretion support health productivity management raising awareness proper hydration immunoglobulin iga antibody plays crucial role otsuka pharmaceutical launched kenko shacho healthy otsuka pharmaceuticals website includes information section mucosal immunity exploratory rd demonstrated lactic acid president community website management titled protect heat disorders section presenting bacteria b heightens function mucosal immunity executives across japan network access information content based japan sport associations guidebook lowers probability catching common cold services support health productivity management prevention heat disorder sports activities first enhance services membership launched edition another initiative heat disorders prevention website comprehensive measures health promotion among people created collaboration weather forecasters working age collaboration local governments associations activities raising companies organizations awareness topic addition otsuka pharmaceutical factory sells os oral rehydration solution provides operational womens health support oshiete kakure dassui iinkai organization experts womens health carry activities across japan raises awareness ways prevent treat dehydration spread accurate understanding mental physical becomes critical changes experienced women related health issues well solution issues also provide broad information concerning nutrition enhancing womens health otsuka pharmaceutical website oathas program developing otsu skin care research institute healthy aging supporters targeted pharmacists provide health support local communities enabling participants otsu skin care research institute performs rd cosmedics acquire knowledge also practical skills required wanted improve peoples health within also health support without ensuring skin bodys protective covering cared focusing ingredient amp substance otsuka health comic library found naturally body developed energy signal amp began publishing otsuka health comic library active ingredient supports skin turnover encourages promote sound growth development health habits among melanin excretion body contained main children next generation produced editorial supervision products innersignal series ulos contains moisturizing japan medical association japan society ingredient amp based otsukas proprietary formula school health endorsed japan pediatric society product line steadily expanded include moisturizer library seeks convey basic health knowledge children covering sunblock skin wash refresh sheets shampoo whitening topics makeup human body nutrition care grown brand offers total skin care broad easytounderstand manner medium comics body head toe every year choose different theme publish new volume adenosine monophosphate comics donated elementary schools special needs maintaining improving peoples disodium adenosine monophosphate ot adenosine monophosphate moisturizing ingredient schools japanese schools overseas public libraries daytoday health suppresses production melanin prevents skin blemishes freckles goal nutraceutical business support maintenance improvement peoples health worldwide thereby contributing longer healthy life expectancy end address yettoemerge needs social issues unique concepts eye changes global landscape take challenge creating new value expanding new categories regions combining cuttingedge scientific technological developments unique business model going forward respond various healthrelated social issues continuing implement health awareness activities bring issues forefront offering solutions brand strengthening collaboration external institutions otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report achieve sustainability details healthrelated initiatives visit health people httpswwwotsukacomencsrsocietyhealth details peoplerelated initiatives visit total healthcare company otsuka group aims contribute peoples health conducts httpswwwotsukacomencsrsocietypeople business operations pursuit corporate philosophy consider essential employees able work freely vigorously good health therefore promoting proactive measures enhance employees health working resolve health issues business operations initiatives resolve health issues measures enhance employees health proactively providing information supporting various establishing workplace people treatment continue activities case taiho pharmaceutical working case taiho pharmaceutical seeking resolve unmet medical needs cancer patients proactively providing information recognizing employee precious human resources taiho cancer however due sensitivity individual experiences worldwide taiho pharmaceutical promotes discovery pharmaceutical aimed establish workplaces limited occasions come across detailed taiho pharmaceutical performs proactive activities communicate development anticancer agents also undertakes diverse employees treatment cancer diseases information portal site provides information concerning product information proper use information healthcare diverse activities including support projects aim address continue working organizing inhouse systems providing systems consultation services available employees professionals scientific impartial manner manufacturer challenges oncology area proactive information anticancer agents published handbook anticancer consultation service promoting awareness raising activities families developed cancer diseases well provision agents patients since summarizing mechanism volunteers human resources department including importance cancer prevention examination site also action effect drug symptoms timing frequently occupational nurses public health nurses established pages sharing actual treatment experiences employees supports various activities experienced adverse reactions seek medical advice cancer patients work support team present worktreatment families deepen understanding participation readyfor sdgs sdgs medication record sheet also first japanese support project led systems harmonizing work identify requirements experience recognize matching platform provided corporations pharmaceutical company publish guide proper use treatment extending leaves cancer patients eliminating significance working members taiho pharmaceutical anticancer drugs healthcare professionals present readyfor inc ceiling number leaves considerations transfers provider anticancer agents continue proactively provide proper information path return job also formulated guide recognition initiatives received gold prize supporting diverse projects address challenges field following activities oncology crowdfunding work support employees cancer also two consecutive years ally declaration formulated summarizing information regarding work support award cancer survivorship sponsored ally community distribution booklet twenty since employees cancer broadly disseminated workplace cancer survivorship private project committed supervised appearance support center national cancer information intranet human resource seminars cancer employment center hospital booklet targeted patients receive cancerrelated information portal site cguide r elevant employees may change position possibility transfer cancer treatments aya generation adolescents young portal launched employees cancer disease close moving across japan position possibility transfer limited region adults teens families friends persons system enables employees return job within three years leaving living together shares information regarding problems living one every two japanese considered develop company due special reasons including cancer refractory diseases designated national government may occur treatments solutions distribution booklet fertility preservation handbook fertility preservation handbook twenty cancer patients thinking cancer patients thinking child providing consultation service truly needed support systems child since manufacturer engaged oncology area half century taiho supervised fertility preservation support survivorship support pharmaceutical culture warmly support employees cancer diseases department cancer institute hospital jfcr since strengthened employment support revising employment rules documentary film things know become systems enhancing consultation services types symptoms diseases cancer patient screened free kitajima plant style coping vary among individuals endeavor make best possible efforts sincerely pursuing support truly needed employee akira mita deputy director human resources department taiho pharmaceutical communicating value health broadly continuously maintaining improving health employees families otsuka holdings published otsuka health comic library disorders yet become common raising otsuka holdings undertakes activities promote employees womens health conditioning immunity years communicate mechanism body awareness proper hydration also promoted dietary health cooperation otsuka pharmaceutical health approximately participants total diseases health easytounderstand manner education communicate importance nutritional balance insurance association healthcare professionals seminars held online due covid donated elementary schools public libraries across japan maintain promote womens health also providing health management personnel pandemic nutraceutical business developed sciencebased information disseminate correct knowledge concerning physical group company activities include health otsuka pharmaceutical also opened products provided information leveraging knowhow mental changes womens health solutions seminars group employees families inhouse seminars education support pharmaceutical business since idea heat based knowhow expertise acquired rd based knowledge group business started concerning alcoholrelated issues leveraging soybean products seminars held annually knowledge pharmaceutical business major cities across japan themes december health seminar ssenisub lacituecamrahp ssenisub lacituecartun otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report details quality dorelated initiatives visit quality httpswwwotsukacomencsrsocietyquality help build sustainable society otsuka group guided enduring philosophy customers first quality first pursues quality stages value chain promotes initiatives taking account environment society human rights production quality research procurement control patient logistics sales marketing customer service development customer safety ethical considerations sustainable procurement groupwide cooperation control maintenance appropriate promotion sincere response inquiries accordance laws corporation business customerfirst qualityfirst product quality business enhanced information access reflection company guidelines collaborators otsuka group complies laws continuity planning deliver highvalue products services activities rd times necessary apply across entire value chain otsuka regulations administrative instructions healthrelated company customers group company otsuka group establishes dedicated various methodologies verifying efficacy group engages business activities industrial standards also ensure rigorous control maintenance formulates observes code customer contact points staffed safety otsuka group complies compliance laws regulations working get iso iso fssc product quality throughout distribution practice expands jpma specially trained personnel response certified addition observe laws related laws ordinances respecting environment pharmaceuticals food products promotion code prescription drugs inquiries match characteristics regulations countries perform guidelines striving uphold human rights new suppliers beverages furthermore transport also established expert panel drugs quasidrugs food products quality control quality assurance based bioethics scientifically valid transactions determined gxp implement postmarketing safety pharmaceuticals registered vehicles comprising people several respective products opinions methodologies viewpoints carried due diligence together control establishing global safety authorized access restricted areas departments perform reviews requests regarding products services preservation environment safety business collaborators entire surveillance system collect monitor emergency also exchanged mous marketing plans sales promotion shared within group management otsuka group promote sustainable safety information concerning adverse events shippers warehouse owners materials purpose product development collaborators transport disaster procurement aim realizing gxp good x practice general term good practice improvement part system business continuity standards ministerial ordinances regulations guidelines sustainable society established governments public institutions planning ensuring safety reliability promoting sustainable procurement throughout group drug healthcare information provision activities expected promote sustainable procurement activities throughout otsuka group established employees otsuka sustainable procurement task force made otsuka holdings otsuka fiscal covid pandemic made collecting information person difficult however pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka otsuka pharmaceutical conducted timely information provision activities online thereby ensuring foods otsuka packaging industries otsuka techno en otsuka pharmaceutical task force access drug healthcare information whenever needed ensuring thorough infection formulated otsuka group procurement policy otsuka group sustainable prevention procurement guidelines conducts surveys sustainable procurement activities business partner drug therapy expect employees otsuka pharmaceutical continue yasunobu harada collaborators using selfassessment questionnaire saq well inhouse training given kazumi goto appropriate information provision activities ensuring compliance come project office task force launched covid pandemic meeting sessions held st lukes international university ideas information provision using online tools channels procurement exclusively online nevertheless discussion vigorous director pharmacy department st otsuka holdings lukes international hospital various kinds wild birds come visit biotope tokushima itano factory every season biotope promotion customercentric management inhabited insects including dragonflies october otsuka group announced declaration customercentric commitment way putting corporate butterflies clean cooling water used philosophy practice promotion customercentric management toward groups materialities mediumterm water scorpion dragonfly beetle factory recycled pouring back pond management plan conducting business recognize respecting consumer rights important human rights issue frogs water scorpions many animals declaration customercentric commitment establishes basic policies stating commitment social responsibilities live ground biotope area covered corporation fulfill pursuing customercentric management making appropriate decisions based dialogue leaf mold raise beetles larva stakeholders biotope compound formed german words bio life hare daurian butterfly top place signifying place indigenous wildlife redstart flourish nature otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report present examples measures taken value chain measures business collaborators aimed sustainable procurement global initiatives production department product quality department across entire value chain otsuka group engages business efforts updated otsuka group procurement policy production departments otsuka group employ traceability otsuka pharmaceuticals product quality operations activities safe reliable socially acceptable compliance takes account factors human rights labor issues system covering stages value chain raw material pharmaceutical business nutraceutical business jointly hold laws regulations commencing transactions environment anticorruption measures formulated procurement production distribution sales thereby enabling annual global product quality meeting meeting supplier perform screening checks ensure quality otsuka group sustainable procurement guidelines provide thorough management throughout entire supply chain attended approximately managers quality supervisors raw materials guarantee stable procurement japan specific descriptions provisions vision moreover years global production meeting pharmaceuticals nutraceuticals countriesregions also conclude basic transaction agreement case new policy shared business collaborators held aiming enhancement production technologies including japan participants shared companies measures supplier transactions determined carried order ensure stable supply products perform sharing information groupwide plant manager future business expansion approaches product due diligence advance risk assessments key raw materials clarify nature meeting held virtually discussed challenges inspection amid covid pandemic aim mutually sustainable development fair potential risks take countermeasures also measures around stable supply occupational health safety addition quality performance award established equitable transparent procurement establishment make sure source raw materials multiple companies covid pandemic meeting approximately recognize quality control initiatives efforts made healthy relationships business collaborators principle participants including management executives train people quality control raise awareness countriesregions otsuka group procurement policy reflecting customer feedback otsuka group companies accordance corporate vision otsukapeople creating new products group company establishes dedicated customer contact feedback redesigned container easier open better health worldwide international norms conducts procurement activities responsible way otsuka points patients healthcare professionals general efforts develop improved easiertouse products delivers innovative safe secure highquality products order contribute construction maintenance consumers provides appropriate training employees recognized good design award sustainable society well health people around world related departments approach helps us deepen furthermore enoras liquid eternal use communication customers provide appropriate information adopted package design takes consideration variation relationships suppliers reflect customer feedback suggestions product color vision among users product line received cud collaborator many suppliers otsuka group aims build good relationships mutual sustainable improvements certification making easier tell product variations apart development shared understanding based fair exchange appropriate information opinions one product improvement os os jelly expected help improve patient adherence reduce supplier selection produced otsuka pharmaceutical factory products risk medication errors healthcare professionals otsuka group selects suppliers fair transparent manner based comprehensive assessments supplier foods persons medical conditions received feedback thirdparty certification ensuring product color scheme easy elderly individuals customers receiving treatment people understand quality costs quantity delivery terms compliance laws regulations promotion environment preservation etc dherence refers patients actively understanding meaning significance need nursing care others said difficulty treatment taking medicine correctly rather discontinuing medication responsibilities toward society opening cap muscular strength issues based accord realization sustainable society otsuka group strives maintain procurement activities reflect consideration human rights labor environment nontolerance corruption compliance otsuka group companies observes applicable laws rules otsuka employees supplier employees must act times highest level ethics consistent social norms otsuka holdings co ltd september part otsuka groups efforts promote sustainable began presentations business collaborators share procurement otsuka sustainable procurement task force details procurement policy companies made otsuka holdings five group companies participated first year also conduct common saq formed task force members taking steps prepared global compact network japan provide feedback promote groups overall sustainable procurement including relevant companies end received revision procurement policy formulation sustainable questionnaire responses companies procurement guidelines conducting saq presentations otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka business collaborators chemical otsuka foods otsuka packaging industries otsuka techno en otsuka pharmaceutical added march otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report details environmentrelated initiatives visit environment httpswwwotsukacomencsrenvironment global group contributes health people worldwide otsuka group works introduced co free electricity green introduced solar power generation system sincerely reduce impact businesses global environment seeks power certificates inhouse consumption contribute creation sustainable society protect nature future since otsuka group introduced cofree countermeasure climate change otsuka group earth support solution social issues related global environment otsuka electricity renewable energy sources extending set goal reducing co emissions group formulated environmental policy activity guidelines determined use manufacturing sites fiscal reduced co toward goal promoting utilization emissions approximately tons equivalent annual renewable energy improving energy use efficiency materialities environmental initiatives climate change resource recycling emissions approximately households introduction cogeneration systems including solar conservation water conservation set goals carrying activities introduction renewable energy power cofree electricity generation systems aimed achieving addition five domestic group companies purchased introduced solar power generation systems green power certificates switching green power inhouse consumption kushiro factory otsuka sales sites headquarters five group companies pharmaceutical factory otsuka pharmaceutical india goals goal fy reduction co emissions compared fy japan offices thereby reducing co emissions estimate result annual co emission reductions approximately tonsyear approximately kushiro factory otsuka going forward group work together toward pharmaceutical india climate change fy ic tr e dm ucis ts ii oo nn fr e rd eu nect wio b lt eh r eo nu eg rgh co emissions scopes co emissions scope realization decarbonized society ultimately otsuka group compared fy co emissions japan overseas results tco tco tco sustainable society optimizing maximizing energy use introduction renewable energy fuel conversion exercising synergistic effects among group companies goal fy reduction simple incineration landfill compared fy including carbonneutral electricity utilizing certificates equal renewable energy goals goal fy higher content recycled plantbased materials emit co pet bottles calculated co emissions residential sector fiscal otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical kushiro factory otsuka otsuka pharmaceutical india resource otsuka chemical otsuka foods pharmaceutical factory recycling total waste volume simple incineration landfill fy conservation results evaluating water risk manufacturing sites waterrelated risk groups business activities also considering environmental risk region also important formulate analysis records site implement sustainable growth diverse business models comprehensive risk assessment utilizing detailed water goals goal fy improvement water use efficiency compared fy otsuka group operating around world since data collaborating among group companies pursue otsuka group conducted primary water risk assessments water resource conservation improve use efficiency water consolidated manufacturing sites using water risk identifying regional risks promoting specific research conservation fy water usage water use efficiency water resource risk assessment assessment tool aqueduct developed world resources collaboration among group companies taking results million manufacturing sites companies institute wri understand minimize impact measures regionbased management effective utilization based performance manufacturing sites consolidated otsuka group aqueduct water stress map breakdown region water consumption region otsuka group scope direct emissions scope indirect emissions energy sources scope indirect emissions otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka foods acquisition integrated iso certification otsuka group otsuka groups first iso certification acquired groups five major companies japan otsuka holdings since worked acquire certification supervising organization acquired iso integrated europe manufacturing sites group certification august integrated environmental company promoted activities goals management systems outlined certification achieve environmental goals strengthen environmental initiatives make japan set company groupwide efforts achieve goals north increasing severity environmental acquired tokushima factory otsuka chemical present tokushima factory america water stress issues recent years companies otsuka chemical tokushima factory otsuka foods east asia high cquired certification companies japan overseas december called upon contribute high otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical south asia resolution issues north africa moderate high including subsidiary okayama taiho pharmaceutical otsuka chemical strengthen groupwide efforts otsuka foods low moderate southeast south toward efficient effective asia america low environmental activities otsuka use dry low water data source wri aqueduct otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report measures covid entire world forced mobilize novel viral threat otsuka group implementing measures prevent spread placing top priority safety health express deepest condolences loved ones people lost lives stakeholders due covid extend sincere sympathies persons infected virus families affected persons thorough implementation infection sales marketing ongoing initiatives toward maintaining support activities prevention measures major group companies pharmaceutical business improving health japan provided pocari sweat bodymaint calorie employees continue work safely enable continuous provision information healthcare new normal environment otsuka group mate os otsuka group products well medical covid pandemic otsuka group introduced new work professionals restrictions visits medical continuing initiatives support resolution local health masks protective suits local governments style systems including telework implemented appropriate institutions pursued hybrid approaches combine real issues activities communicate importance health related organizations infection prevention measures urged employees make world digital eg enhancing digital promotion maintenance promotion many events overseas addition providing beverages food wideranging lifestyle changes strengthening online access healthcare professionals suspended postponed pandemic otsuka products pharmaceuticals made donations local introducing smartphone apps pharmaceutical provided innovative support medical facilities red cross others example measures business continuity information provision example interhigh school usbased sozosei foundation donated total us every stage value chain otsuka group customer service competition season provided pocari sweat along dollars approximately million yen four organizations working increase operational efficiency including promoting pharmaceutical di operations telephone inquiries updated information concerning measures heat disorders related mental health kidney diseases five charitable diverse flexible work styles well digital transformation taken staff working home thereby ensuring business physical condition management exercise order organizations accelerating initiatives new continuity supporting medical settings time support high school students enable safe substitute public interest foundation established otsuka us carries normal thereby contributing peoples health worldwide restrictions visits medical institutions contact center competitions prefecture activities accordance otsukas sustainability mission including awareness activities mental health kidney diseases disaster relief contribution awards initiatives otsuka pharmaceutical factorys dubai singapore indonesia otsuka pharmaceutical local communities clinical development intravenous drug information center received bcp award cohosted pocari sweat virtual run running event group company striving minimize delay recognizes sustainability stability call centers utilizing smartphone app collaboration national pandemic might cause clinical studies example measures di drug information operations pharmaceutical information management operations governments addition online seminars communicating otsuka pharmaceutical include launch fully remote n award program initiatives contact centers determined assessment importance hydration exercise otsuka personnel review panel participating firms organized call center japan editorial clinical studies department ric telecom co ltd coorganized epartners inc working nutraceuticals pharmaceuticals fields provided information help address issues related lack exercise production quality control patient mental health customer safety formulated covid infection prevention control manual implemented thorough infection control measures regular checking body temperature staggered lunchtimes otsuka pharmaceutical regards responsiveness avoidance three cs closed spaces crowded places covid pandemic one social closecontact settings also enhancing business continuity responsibilities since september planning developing laborsaving technologies among comarketed quick navicovid ag rapid measures maintain stable supply system additional measures diagnostic test kit confirms test results ensure stable supply otsuka pharmaceutical placing minutes advance orders raw materials evaluates second vendors manufactured comarketed denka company limited increasing stocks raw materials product quality departments otsuka group promote thorough measures maintain improve quality maintenance project combining blue color pocari sweat virtual run seeitblue part global campaign mental health ensure safety management accordance business makeitblue aimed increasing awareness mental health crisis characteristics company example otsuka amidst covid pandemic singapore pharmaceutical replaced direct visits remote auditing support municipalities covid pandemic photo provided manufacturing sites contractors using video footage suginamiku site otsuka personnel range roles multiple locations across japan able participate verification process contributing energized communication quality improvement otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report details governancerelated initiatives visit governance httpswwwotsukacomencsrgovernance shareholders meeting corporate governance electsdismisses electsdismisses electsdismisses otsuka holdings co ltd company committed promoting sustainable increase corporate value medium long term realizing corporate philosophy otsukapeople creating new products better health worldwide meet corporate consults board directors ap cce ora ut nio tin na gl aa uu dd ii tt ss audit supervisory board commitment adopts basic policy making transparent fair timely decisions fulfilling corporate social governance recommends directors outside directors eu mdi bt e r ss u p oe fr v wis ho ory b ao ra er committee appointsdismisses outside members responsibility living expectations stakeholders including customers business partners employees local communities shareholders ongoing dialogue president representative director ceo cooperates cooperates accounting audits instructs reports accounting auditor company discloses basic approach corporate governance corporate governance guidelines available corporate website internal audit department cooperates corporate governance guidelines corporate governance report april httpswwwotsukacomencsrgovernancepdf httpswwwotsukacomjpcsrgovernancepdf approval meetings prior governanceguidelinepdf governancereportpdf available japanese material matters groups boards consultation management corporate ex post guidance auditors facto reports overview corporate governance structure governance structure march subsidiaries shareholders meeting board directors audit supervisory board members etc aim promoting sustainable growth company company audit form organization increasing corporate value medium long term supervisory board board directors audit supervisory board members board directors also includes outside directors advances directors outside directors independent directors board directors convenes regularly month holds audit supervisory board members attend express opinions execution management plans supervises company 's management order enhance profitability capital term directors year extraordinary meetings necessary make important business meetings board directors monitor performance decisions supervise execution operationsto clarify duties directors terms legal compliance soundness investment efficiency company secures soundness audit supervisory board executive responsibility fiscal year term directors management audits striving improve established solid corporate governance structure lives members outside audit independent directors social expectations ensuring audit supervisory supervisory board members set one year effectiveness audits audit supervisory board members also share information exchange opinions appropriate board members independent accounting auditor kpmg azsa llc corporate governance committee relevant departments including internal audit department directors audit directors ' performance duties note eloitte touche tohmatsu llcs term office companys accounting february company established corporate internal control department administration department collaboration accounting auditor well internal auditor expired conclusion annual shareholders meeting held governance committee aim increasing transparency finance accounting department well accounting audit department march meeting kpmg azsa llc elected new accounting auditor objectivity management advisory body board auditor initiatives strengthen corporate governance directors committee discusses matters relating corporate governance including nomination directors audit internal audit department establishment otsuka holdings three outside directors three outside audit supervisory board term directors set one year members supervisory board members remuneration system companys internal audit department reports directly decision adopt directors retirement benefits system effectiveness board directors evaluated remuneration standards directors reports results president department regularly conducts audits based corporate officer system adopted system granting stock options conditional progress two outside audit supervisory board members mediumterm management plan introduced deliberations board directors committee consists internal audit rules verify operations executed three outside audit supervisory board members corporate governance guidelines revised president director charge administration appropriately efficiently regard assets business stock options performancelinked remuneration introduced corporate governance committee established outside directors four march president serves company affiliated companies department stock publicly listed december started evaluate effectiveness board directors based questionnaires completed directors audit chair committee submits audit reports president directors audit first mediumterm management plan announced supervisory board members supervisory board members need improvement two outside directors three outside audit supervisory board started hold reporting meetings outside directors members outside audit supervisory board members improve content deliberations department recommends remedial actions later confirms understanding groups management business nomination implementation thereby contributing optimization second mediumterm management plan announced three outside directors two outside audit supervisory board two female directors corporate governance committee discusses validity business execution department also shares information members corporate governance guidelines revised fairness matters related appointment cooperates audits audit supervisory board members otsuka group global code business ethics established third mediumterm management plan announced otsuka group global anticorruption policy established restricted stockbased compensation plan introduced dismissal directors audit supervisory board members accounting auditor corporate governance guidelines established four outside directors three female directors reports board directors regarding candidates internal whistleblowing system otsuka holdings major otsuka group global policy conflict interest established audit supervisory board members committee obtains internal control department group companies established reporting independent body outside company approval audit supervisory board prior reporting company views internal controls integral component board directors corporate governance functions together compliance composition board directors committees candidates put forward representative risk management established internal control board directors audit supervisory board corporate governance committee directors department department charge compliance risk ratio independent outside directors ratio independent outside audit ratio independent outside directors remuneration management improve internal control system supervisory board members corporate governance committee discusses matters internal control department promotes otsuka group related remuneration system remuneration standards global code business ethics otsuka group global rules directors audit supervisory board members otsuka holdings affiliated companies also works reports board directors establish promote compliance programs risk management directors directors directors addition committee deliberates matters related programs company status establishment enhancement corporate governance structure operation programs regularly reported board reports board directors necessary directors audit supervisory board accounting auditor otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report remuneration directors audit skill matrix directors audit supervisory board members internal control department handles internal controls supervisory board members regarding financial reporting company affiliated order establish effective corporate governance structure supports sustainable growth company appoints individuals wideranging business experience advanced expertise broad fields extensive knowledge directors audit supervisory board companies department formulates rules manuals companys remuneration plan directors audit members table summarizes areas experience expertise directors audit supervisory board members pertaining internal controls provides training ensures supervisory board members designed achieve sustainable employees thoroughly understand operational rules growth enhanced corporate value medium long global technology strategic finance legal company healthcare major department also works cooperation internal audit term group based corporate philosophy also rd planning compliance risk administration qualifications business production marketing sales accounting management analysis public health etc department continuously monitor status operations ensuring functions business execution basis internal control system management management supervision exercised appropriately maintaining ichiro otsuka personnel reliably evaluated transparency fairness tatsuo higuchi evaluation effectiveness board directors remuneration levels yoshiro matsuo january february every year company conducts considering need acquire motivate outstanding yuko makino questionnaire survey directors audit supervisory personnel take responsibility companys global shuichi takagi board members results survey reviewed company business activities company sets remuneration levels fully sadanobu tobe attorney reviewed evaluated board commensurate roles responsibilities expected directors meeting march personnel also considering levels companies directors masayuki kobayashi questionnaire items follows company considers benchmarks based scale industry noriko tojo composition board directors business model makoto inoue directors understanding knowledge business fields specific management strategies plans remuneration system yukio matsutani md cooperation outside directors regard remuneration directors responsible business ko sekiguchi cooperation audit supervisory board execution company formulated remuneration system yoshihisa aoki operation board directors meetings closely linked performance individual fiscal years mayo mita governancerelated matters well medium long term emphasizing function board directors determining sustainable enhancement corporate value remuneration yozo toba direction management strategy consists fixed remuneration basic remuneration performance audit supervisory hiroshi sugawara cpa ii monitoring business respect execution linked bonuses sharebased payments emphasizing link board yoko wachi attorney management strategy shareholder value remuneration outside directors audit members iii understanding perspectives major investors supervisory board members comprises fixed remuneration kazuo takahashi stakeholders basic remuneration light duties iv risk management rationale selection outside directors outside audit supervisory board members v cooperation information sharing operating method determining content company remuneration individual directors attendance rate support system outside directors board directors receives recommendations audit rationale selection board overall functioning board directors appropriateness remuneration system remuneration supervisory directors board perspective effectiveness levels performance evaluation performancelinked meeting meeting bonuses sharebased payments corporate yukio matsutani mr yukio matsutani abundant experience extensive knowledge healthcare governance committee consists president welfare field well high level expertise overall health care also provided appropriate valuable suggestions advice companys management summary evaluation fiscal director charge administration outside directors independent standpoint outside director objective expert viewpoint overall opinion improvements made based recommendations board determines ko sekiguchi mr ko sekiguchi abundant experience track record extensive knowledge corporate previous year believe board individual remuneration directors follows manager high level expertise network pharmaceutical business also provided appropriate valuable suggestions advice companys management directors functioning appropriately standpoint outside independent standpoint outside director objective expert viewpoint effectiveness nonetheless results confirmed need president delegated deciding specific payment directors yoshihisa aoki mr yoshihisa aoki abundant experience track record extensive knowledge improvement areas role amounts individual fixed remuneration basic remuneration corporate manager abundant experience expertise network food industry also provided appropriate valuable suggestions advice companys management company holding company methodologies used directors individual performancelinked bonuses independent standpoint outside director objective expert viewpoint monitoring subsidiaries approaches cooperation director excluding outside directors pursuant resolution mayo mita ms mayo mita securities analyst abundant experience corporate analysis based group companies board directors accordance delegation high level insight objectively observing analyzing companies providing appropriate valuable suggestions advice companys management president makes final decision remuneration amounts independent standpoint outside director objective expert viewpoint based deliberation reports corporate governance hiroshi sugawara mr hiroshi sugawara specialized knowledge certified public accountant abundant committee regarding remuneration levels outside experience knowledge many businesses areas audit yoko wachi ms yoko wachi wellversed corporate legal affairs specialized knowledge insights individual sharebased payments director excluding supervisory based abundant experience attorney board outside directors determined resolution board kazuo takahashi mr kazuo takahashi held major positions internal control departments many years members abundant experience knowledge corporate management directors based reports performance evaluation etc corporate governance committee outside directors outside audit supervisory board members given risk conflict interest general shareholders company believes outside officer qualifies independent directorauditor otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report content remuneration directors excluding outside directors total remuneration directors audit supervisory board members content remuneration directors excluding outside directors listed total amount total amount type remuneration million number remu tyn pe eration pa fy ixm ee dn vt riae bth leod including policy deter mm inu ne gr tit mio inn gc r ce nt ditions remuneration classification mre im lliu ne r oa ft yo en n remuf nix ee rd tion sh pa ar ye mb ea ns ted bonus eligible officers fixed remuneration directors holding company determined based duties responsibilities including directors formulation group strategies monitoring group operations strengthening corporate governance outside directors fixed cash remuneration directors serve concurrently directors subsidiaries operating companies determined based duties responsibilities including execution business based group strategies formulated otsuka remuneration fixed holdings formulation strategies operating company strengthening corporate governance remuneration audit supervisory board members shall exceed upper limit remuneration resolved shareholders meeting outside audit supervisory fixed remuneration paid equally every month board members remuneration paid lump sum certain timing every fiscal year amount calculation method determined total performance cash based rate achievement fiscal years targets consolidated revenue consolidated operating profit outside directors audit consolidated business profit rd expenses progress respect mediumtolongterm consolidated supervisory board members linked bonus variable performance targets appropriate business management compliance corporate governance along individuals personal performance directors company concurrently serve employees current fiscal year outside directors audit supervisory board members received total remuneration million companys subsidiaries services company introduced sharebased payment plan reflects progress achieving targets third directors audit supervisory board members mediumterm management plan covering period fiscal fiscal plan restricted stock allocation agreements stipulating conditions including transfer restrictions set period noncash concluded grantees plan designed function effective remuneration system combining sharebased multiple release conditions transfer restrictions including set performance evaluation period performance restricted stock payment achievement principle granting restricted stock requiring evaluation performance several fiscal years sustainability management structure otsuka holdings variable time first fiscal year specific timing granting restricted stock fiscal year items requiring evaluation performance single fiscal year time first fiscal year evaluation period items requiring evaluation performance otsuka group sustainability promotion committee develop systems area sustainability promotion several fiscal years established chaired director charge update promotion plans necessary committee overview noncash remuneration restricted stock determine number shares allocated grantees restricted stock standard number shares set sustainability promotion otsuka holdings members comprise group officers charge areas relating fiscal year individual giving consideration performance duties responsibilities weighting versus fixed remuneration basic remuneration based standard number shares shares allotted series fiscal year time first fiscal year evaluation period several fiscal years according committee promotes sustainability entire otsuka sustainability supply chain environment human release conditions table restricted stock allocation agreements concluded grantees stipulate transfer restrictions restricted stock shall removed company shall group acting engine discussions decision resources corporate governance compliance risk acquire shares without paying compensation certain events occur making regarding direction sustainabilityrelated management public relations sustainability composition remuneration directors remuneration directors subsidiaries activities plans measures committee meetings promotion ir corporate planning departments excluding outside directors operating companies otsuka group held regularly discuss direction evaluate activities otsuka holdings functioning secretariat remuneration plan emphasizes mediumtolongterm remuneration directors subsidiaries operating enhancement corporate value designed performance companies determined based duties responsibilities apply deliberation linked remuneration percentage total remuneration varies including execution business operating companies based otsuka holdings otsuka group sustainability promotion leader according companys singleyear mediumtolongterm group strategies formulated company formulation board directors otsuka holdings director consolidated performance strategies operating companies strengthening corporate approval rough guide ratio remuneration remuneration governance shall exceed upper limit remuneration type performancelinked bonuses designed variable resolved shareholders meeting proposal approval promotion range fixed remuneration sharebased payments noted restricted stockbased range fixed remuneration performance compensation system newly implemented fiscal also group companies linked bonuses sharebased payments combined roughly apply directors excluding outside directors certain otsuka group sustainability promotion committee secretariat executives charge maximum total remuneration total major subsidiaries group examine promote direction strategy field sustainability fiscal year evaluation allotment ratio summary release conditions allocation timing promotion promotion promotion condition incumbency subject fiscal year series allocated year taking single fiscal single fiscal year standard number however shares released combined incumbency condition year evaluation period shares consolidated revenue operating profit target achievement group companies rate less share information promote activities within field evaluation period three fiscal years evaluation period value may fiscal fiscal field promotion committee members promote throughout series b fall value achievement th e sh amar ee mor e ah te hh er e ste fs ta hl elo pc ea rt ie od cumulative amount planned value consolidated share information promote activities within seven main group standard number business profit rd expenses third medium operating companies sustainability public relations departments mediumterm shares evaluation period two fiscal years term management plan performance targets fiscal fiscal cumulative amount actual value consolidated shares two years allocated otsuka otsuka time start period business profit rd expenses evaluation period otsuka pharmaceutical taiho otsuka otsuka otsuka medical pharmaceutical pharmaceutical warehouse chemical foods evaluation period three fiscal years factory devices evaluation period value may fiscal fiscal series c fall value shares three years allocated satisfaction time start period cumulative amount consolidated cost capital standard number calculated accordance consolidated capital cost mediumterm cost shares evaluation period two fiscal years ratio evaluation period capital condition fiscal fiscal cumulative amount actual value consolidated shares two years allocated net operating profit tax evaluation period time start period otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report directors audit supervisory board members march directors outside directors och tsir uo ka ha igts uu co hi mo th si uro mu ak ti u tani k seo kiguchi ao os kh iihisa c r dh e irpa ei r cr e tm oea rnn aa tn ivd e p r dr e ie rp es ri ced ts oe en rn ct en oid v e de irn eio ctr ranaging outside director outside director outside director profile profile profile profile profile profile apr joined otsuka pharmaceutical factory inc mar joined otsuka pharmaceutical co ltd apr joined otsuka pharmaceutical co ltd apr intern pediatric department st lukes international hospital apr joined mitsubishi corporation apr joined itochu corporation jun executive director director consumer products development jun senior managing director otsuka pharmaceutical co ltd jan vice president associate general manager general affairs oct joined ministry health welfare present ministry health may joined boston consulting group jun executive officer itochu corporation division otsuka pharmaceutical co ltd pharmavite department otsuka pharmaceutical co ltd labour welfare jan general manager sterrad business division johnson johnson apr managing executive officer president food company itochu jun managing director responsible consumer products publicity nov executive deputy president executive director otsuka jun vice president general manager general affairs aug directorgeneral health policy bureau ministry health labour medical k k present johnson johnson k k medical company corporation promotion development division otsuka pharmaceutical co ltd pharmaceutical co ltd department otsuka pharmaceutical co ltd welfare nov president representative director janssen kyowa co ltd apr member board senior managing executive officer dec executive director research development otsuka jun executive director responsible us business otsuka nov senior vice president general manager general affairs aug director national sanatorium tama zenshoen present janssen pharmaceutical kk president food company itochu corporation dea cy p r e ph x ea p acr rr um mes ta aie vc cn ee et u ua dtt teii ivc cpea au l l tf fyia r pc ce rt tc eo ot sor riy ydr e ion nnc ct ts au nk da p rh ea pr rm esa ec ne tu att ii vc ea l df ia rc et co tory r onc ts uka j ju un n p p c eh xr oe ea cr um l te ta id vnc ete u dnt ii rdc ea crl e oc p ro r oe tl e st n ud k pv ad rmire ac ct eo ur io cat ls u ck oa p lh tdar maceutical jul e cxe oatp e n r lnr g tt dm il n gn e dlt iw ri eoi ct nh tos r cd osit u rio pkn oaa rp al h tr ee r amp mn cs e ii nub iti sl ti ct ray l f ico n l e olg ta sl u kaff hi ors l da nd g mp e acr r p v ue c tes si ip de r een st di ena ct ti oo rn n oel r ti snn uas kt ti ou n ht ae ol l duf np gvu seb r cl sic ot h oe la f dl ht h e ca ult rh r ea nn td welfare j ju ac nl c ru eh p pa r ri e erm sea e nn ta aa tn ivvd eis od dri ir r e j eac ct n osr r e j dna k joe awn p aak n c pw r ea l c ed l htd ia japan j mua n ar r od u um ts si ii dn e eis dra ir rt e eiv c ce r r f ofic r tae sutr k co hc rh opu lo c r inao gtir sop n co r oa c u io r lr tn e n c u curr rn ent dec p fare cs ti od yn n cn representative director otsuka pharmaceutical jul p cr oe le tdn cn ud rr er ne tp resentative director ceo otsuka holdings mar ldio inr gm cn oa g ln tg director corporate administration otsuka jun president japan public health association current mp ar r ou ut ts si id de e di ir ec ct r n kei nc e c ixo r inp co ration present solasto corporation jul executive director otsuka holdings co ltd dec executive director otsuka chemical co ltd jan executive director otsuka medical devices co ltd current mar outside director otsuka holdings co ltd current jun executive deputy president executive director otsuka feb president representative director otsuka pharmaceutical mar senior managing director otsuka holdings co ltd current holdings co ltd co ltd jun representative director otsuka pharmaceutical factory inc mar chairman representative director otsuka pharmaceutical vice chairman representative director otsuka holdings co ltd current co ltd mar executive director otsuka pharmaceutical co ltd current chairman otsuka pharmaceutical factory inc current chairman representative director otsuka holdings co ltd current outside directors audit supervisory board members mu ak ko ino tah ku aic gh ii toa bd eanobu e cx fe ocutive director e b mx u ae nic nu aet gi ev se mp er nir te f oct lio executive director mayo bz ao h suir go whi ra mita standing audit outside audit outside director supervisory board supervisory board member member profile profile profile apr joined otsuka pharmaceutical co ltd apr joined tobishima corporation apr senior managing director representative director shinko apr joined baxter limited sep joined otsuka pharmaceutical co ltd foods co ltd present otsuka foods co ltd profile profile profile sep pr r j v v po hi ii et c ci r pe e eu c mk p ptd ro tr r e em r ch eet io ds uf nu l e e td ttk n n ih ci n toe g lp c ds csh uo ica r r oke err op c c l ho oa r tlac r r dot e ole du f f f nt ai ic h gn ca e sa cl n occc c uooo e nr p ill tt gr dd c dc eo e f pu n rt ti nn mcg ee nd te p oa c tr c st um u ke ann tt g j muu l ag r f c c p v p ci h hio eon ca ora e p r rn pl c ct rr ae ea lc c td e eie rdu u ie sefp ni ii oc ca n ta tr st rl ln uec fc kae e p acn pt n l ro ra vif bc c il tneo ei ca u f lona imrt id tgi edv dii eo b ppn u ra e r sio n emt e ns teu n ok ta tp ush kt usa akur pm k haa c mu cic ea ul tical j n ju uol l v e f e c p c eox x r xh oee e eo e sc c cd im u u ud lst te tii icc dnv v va e e eo tl ad dh nle e io rdtp p eld cu u r tnt e oy g p r p p r er r oce e tes si nd u e e kaln n v h e n p ld dr e ir nr r es ge e e cp p stn r r ce e r os oe e n n u lst ta u tk dt kai v v ce e c hd hei emr e mic c c co al r r lc ho ot l du u l itk k nda g j dap e en c cr j e q e ei ac nun ns u iie ou ard rb gt iri ies neh dgo vc e r u idg ira rcj ren h cm l tt nd odt va rr ev n g smsl te mony erj ga nt h ap nna e b n l ae sl ny tts ah ke nc ic e na lu ec grr yu e bt r ji ue mi ps se ias nc n erco g ss sa e nl u c ul nsd rt ta p e hl sr e ee c e loj tan hpt c la atn rd e j j ap n n ar j c c co h f hpi rn oee eee cm mr atd toi c cr io r na cl g lt n ec h u llo ook e f la r n f c ic l g neath gd rmt ie b n cn h f ooc c r e ml n lh tt e ti rl n poin rstg es ss u e k tc neao tm c h dl tset e ud p k c rp cr mle hhs e ee n mn l tdt ci oo n ag lt ss cuu c okk aoa l tl dt f juec c nbt j j v co ouci hn n e tm se e ip ld da tr et dec u ah e id lu u co l e uo dli nt c r ta e u nwtd ts iut l ul c c pch eo ae rr p vp iioo sta ohr la rm ymti ao batn os nu aa r g dp e r mmes e ee n mn tt b c ed l oo li tt st ue k aco uu hrc r oh e ldne n gs apr v c v oi io tc c se e u klp p atr rde e ps si hd ae e rn n mt cei ir r ue e tc c ict alr r co f h h le e dt fa inx nce ep r ce cn ot u tt insu gk da eh po al rd tmin eg ns j man r en e xd eni ca io u p r ir v viv eica dete ip r el rei cm toidit ree nd fit n ap nre cs ei ae nn dt bs uo sf infi ece ss pots rtu fk oa li oh mold ai nn ag gs e c mo e n tl j ju un n v l cti hdc ae rc mh aa nir ana dn ra en pd r er se ep nr te te ivn et dti iv ree c toir c oto tsr u ko cu hk ea fo ico ad l c c oo l td mar ouit ts su idb eis h di ru ecf tj r tg sa un k ha dey ge sc cur oit ie ls dc c u l rt rd e nt j du en c c exo e epr cp uo r ttr im va et ee dn irf ef cic tte osur r k cai rpoct oldo rir g ef ct mc nlr tp isdo rr aa tt ie nf aa cn cc oe u n ta inc gc au nn dt tg j ou cn p ohu uat trs smi id dae ec deuu irt ed ccit ta l rc nu ip p e l ptr odv ni pr ay r kb io na gr em vee lm opb mer e tt cu ok ltd ar r e ex xe ec cu ut ti iv e di ir ec ct r c co forp ora tst ue kf han oc lde n gst cu oka h lto dl cug rs r ec ltd e hx ot es lu c duk inta gv p se h cda irm e ca ltc de r u b cic u ua rl r n ec e pl otd rt f oc lu ior r men n gement otsuka j ju un n v cti oac e n lc tnh dga ir ua dn ss uu pk ea r vf io od rys bc oo r dl md ember otsuka holdings mar e cx ot es ru c puk ota riv ac e te h v e sim c ee ri v c p ia crl ee c dio e e p n al tt rd c er np r oat te su f kin hn oc le n ga sc cco ou n lt tin dg mar ltu dd c u r rs eu np te rvisory board member otsuka pharmaceutical co nov president representative director otsuka foods co ltd mar standing audit supervisory board member otsuka holdings jun executive director otsuka holdings co ltd current co ltd current mar chairman otsuka foods co ltd mar cu ud rri et n supervisory board member otsuka chemical co ltd mar executive director otsuka foods co ltd current yoko kazuo masayuki noriko makoto wachi takahashi kobayashi tojo inoue outside audit outside audit executive director executive director executive director supervisory board supervisory board member member profile profile profile profile profile apr joined daiwa bank ltd present resona bank limited apr joined goldman sachs japan corporation apr joined otsuka pharmaceutical co ltd apr registered attorney law daiichi tokyo bar association apr joined ebaraudylite co ltd present jcu corporation oct joined taiho pharmaceutical co ltd aug joined shearson lehman brothers holdings inc jun vice president general manager diagnostic division otsuka joined kajitani law offices current mar executive director strategic planning ra institute co ltd aug president taiho pharma usa inc present taiho oncology inc jul engagement manager mckinsey company japan office pharmaceutical co ltd jun corporate auditor nichias corporation nov executive director general manager system division ae p p pp r r r e p p l e ctx r r x hde ee e c c iu ud rc mt te e ui nv v ert ne dn n n tti ir r ad de e hc cc rt oeo oe po r r net aso cei oh ht n lso otu gkp pt yah hi v ae ia nr r mm md ci ea ar erc cuie c uc tu sa ro rat e ri ic nn tc nal cic h p l ht ad r maceutical co j f au eu p un bg r g c e p ex r xi er e ee sn c cc u uda lt tgo et id nv vir n e et gi n ad nd ie r rdi e el r e c cc ct tca oetp r r nocl toj u sa cr ukp p ekaa oa n r pei e mn hd aeie c rrl e micc v l ae ado l v r e ip n tvp eo cm c r lea e lst n c co tn ls tu dk holdings j mu pn arr r b e n e pxe x hu u ae en nc ci ri rno u u maer ct g ai ev v v cnue e egc ud de ci tv ip r iri ciles e rr ai ee c c b lt cs n oi cu td r rs e ro n en p nx e hs l e au u tscd drk u md atp cvvpu v eieh st u tay v e r inig cc l aee l l cn spc te e r bser u u ua st k sil c iam nea epnla shtcn g rg om ee tal nr st c ueo er kf u lp imh caa lr nm ca oa g c e e r lu tot di fc al jua nr c oo uu tt ss ii l dd ee da iu c ru ed crit r te n r nu ip che ir av sis cor oy r pb oo ra ar td io n e cm urb er n tsuka holdings mc e k e c exu x x u ee e en su cc c nk uu un vu tt ik rs ii vov vu e ee e ns r dca ii io es rr r es fe e crc c tc l ono oi la rcr r h e hh c ais e ne h e aai ai en ded g fc r oe e ff f l et th rh ni eoe e sn f f rf oa f ao ncfr f em cic hg e c ie st e io ra c e nn cln ed r ky cs hs l et st ere u km nnt e skt g ue ury ni sv n koi cas ui lf f c cc e l nc dt ti rhr loc te e mar executive director otsuka holdings co ltd current jan president representative director otsuka medical devices sep executive director daiya foods inc may executive director head information systems division circle k co ltd current mar senior managing director nutraceuticals business otsuka sunkus co ltd may executive director otsuka america inc pharmaceutical co ltd mar outside audit supervisory board member otsuka holdings aug chairman pharmavite llc oct chairman nardobel sas co ltd current mar executive director otsuka holdings co ltd current mar executive deputy president executive director otsuka pharmaceutical co ltd mar president representative director otsuka pharmaceutical co ltd current executive director otsuka holdings co ltd current otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report discussion corporate governance four outside directors two inside directors discuss corporate governance otsuka holdings corporate governance system effective corporate governance otsuka balance fact two female directors holdings inside directors significant hand growing importance overseas operations company aoki proactive promoting human resources otsuka holdings current structure company familiar overseas business conducting variety board directors executes business audit businesses even though people may share longterm supervisory board feel structure working well vision group ascertaining changing conditions results environment audit supervisory status business detail easy therefore feel board members outside directors exchange candid important company create system setting opinions without reserve think opinions kpis business track business targets respected decision making things stand helped level achievement reliable oversight believe maintain effectiveness corporate governance make business monitoring management practical terms society increasingly calling greater effective separation supervision execution must closely monitor trend work toward improving system sekiguchi moreover think cultivating management personnel considering significance corporate governance important factor properly maintaining governance purpose mission holding company think addition training management skills think otsuka otsuka holdings must ask raise conduct training places emphasis collective strength otsuka group highest level management morality words cultivating sense perspective think fully discuss ethics maintain sound management examine optimal structure otsuka groups sales yukio matsutani ko sekiguchi composition aim going forward outside director outside director mita business environment changing tremendous speed member corporate governance committee member corporate governance committee three female directors provides adequate gender brought factors including covid pandemic yoshihisa aoki mayo mita yoshiro matsuo shuichi takagi outside director outside director senior managing director executive director member corporate governance committee member corporate governance committee charge otsuka group sustainability promotion business portfolio management head otsuka group global environmental council member risk management committee member corporate governance committee otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report expertise front lines enables expeditious discussions mita board meetings hand think must consider high degree transparency receive reference whether current system acceptable stands materials remuneration system comparisons whether functions different order adopted companies information facilitates lively company future exchanges opinions deliberations hand impression slight lack speed matsuo incorporating opinions outside directors structuring years since companys stock listing although systems businesses topic diversity inclusion groups collective strength corporate governance system becoming important society impression appropriate listed company enhanced women active taking lead actual business put firm footing nevertheless issues remaining execution otsuka coincidence women otsuka considered truly global company able play active roles supported ongoing animated discussions among directors special mechanisms promoting women higher ideal form corporate governance received positions improving motivation role sharing women various insightful opinions four outside directors mutual support systems would like discuss points diverse backgrounds move next stage otsuka group must strengthen corporate functions matsuo adoption digital technologies keeping difficult achieved results increasing corporate value corporate governance committee comprises audit supervisory board members well corporate alone way succeed going forward maximize group synergies however amid dizzying outside directors president director charge governance role committee changes according increasingly important establish forum suggesting changes operating environment company administration organized hold wideranging discussions business social environment believe role discussing otsuka must prioritize taking action grow simply playing catchup necessary accelerate nomination remuneration directors otsuka holdings also evolve forum bring together everyones abilities acting evolution looking ahead medium long term stage people openly talk demonstrate key function otsuka holdings lead entire group collective strength group stay ahead understand importance cultivating human global governance operating companies times bring otsukas advantages fore resources management opening company external human resources must aim maximize corporate takagi value premised accepted society otsuka group conducts management operating companies respective operating board directors company operates social impact believe generation management respect diversity originality operating companies new form mechanism system executive directors multiple directors must establish system enables otsuka compete companies promotes global expansion trust verify creation mechanism serve concurrently management teams operating global level global company achieve mediumtolongterm growth weather group expansion help maintain companies bringing together critical external perspectives thoughts issues management faces sustainably governance enable sound group development maintaining unified consistent overall direction end think cultivation diversification management manages diversified businesses personnel essential corporate governance committee matsutani sekiguchi otsuka started expanding overseas early stage decentralized management also requires unifying force company established corporate governance solidified business foundation long fall apart centrifugal force strong committee advisory body board directors history governance still developing since business think otsuka reached stage strengthen deliberate nomination directors audit environment completely different region governance words controls global business supervisory board members remuneration system country think governance difficult coordinate support department established otsuka holdings standards directors corporate governance fortunately due efforts front lines business feel making progress toward strengthening global matters please describe status effectiveness stayed aligned otsukas philosophy governance risk management also important global committee necessary strengthen mechanism governance would like see function enhanced achieved going forward matsutani think committee effective problem aoki takagi current system stage also believe processes sense global governance otsukas operating management operating company allowed appropriate ensure transparency objectivity companies driven excellent management skills certain degree freedom encourage independence hand overseas businesses account half leadership successive management teams however creation innovative ideas also previously pointed sales real terms system may sufficient group grown current scale feel otsuka proactively promoted globalization quite control overseas operations grown extent need reconfigure system otsuka holdings early stage start restrictions foreign otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report central nervous system iv solutions business also making opportunities shifted digital realm progress cooperation otsuka pharmaceutical crucial questions otsuka best make use otsuka pharmaceutical factory aware shift develop products services stage step group governance use digital technology improve efficiency sustainable growth otsuka group strengthening areas promotion new product development monitoring function building system collaboration capture needs new era operating companies matsuo matsuo digital technology strategy passive one matter much businesses expand diversify view something must ahead companies otsuka must continue uphold approach business proceed next stage must set forth digital systems unwavering actualization creativity technology strategy one core strategies passed successive management teams organization next mediumterm management plan sustainability reproducibility important groups future recognized intrinsic aspect business activities rather sticking successful past must view led otsuka become signatory united build structure reproduce vision nations global compact people rally organization otsuka unless appealing company fulfills investment circumstances made difficult import also believe structure board directors worldwide pocari sweat calorie mate corporate responsibilities sustainable society japanbased management globalization progressed needs evolve change line otsuka groups think greater demand products take however take longterm perspective without various countries recent years otsukas governance stage direction perspectives management preventive approach maintaining health future earnings base intend invest mediumto system last evolving groupwide assetsharing supervision maximization group synergies global would like otsuka focus creating products longterm growth staying committed maintaining way various therapeutic areas oncology governance nutraceutical business current business performance otsuka capable identifying overcoming issues looking mita future ideas unlike companies otsukas social role new normal achieving amid growing social trend health awareness continue strive vibrant active company believe otsuka groups wideranging portfolio opinions may differ among diverse types business sustainable society longterm product brand development core diverse management personnel alternative strengths one companies unique one everyone opinion would position able provide comprehensive healthcare senseless lively exchange opinions would worldwide covid pandemic major change accordingly solutions even companys strategy aligned like lay groundwork next stage create impact society peoples lifestyles one greatest changes increased use sustainable approach keeping products businesses organization reproducibility thoughts opportunities risks new normal information technology advances going indefinitely surely difficult era rapid going forward otsukas role future issues think largest impact rapid uptake change otsuka focus short term unique total healthcare company everyone elderly children affects entire medium term long term making decisive addition recent years increasing corporate supply chain making essential companies investments view future may necessary calls contributions sustainability greater prepare situation although every company sort longer demand due demands corporate social responsibility ever already dealing visible primary impacts also changing times mean otsuka holdings otsuka aims achieve sustainable growth contribute need develop flexible system respond secondary shortterm orientation rather vision healthy sustainable society based tertiary impacts strategy looks ahead corporate philosophy business activities help resolve social issues thoughts aoki sekiguchi direction otsuka take issues going find phrase unique total healthcare company otsukas scope business total healthcare company forward appealing think people want lead healthy long extremely important new era enjoyable beautiful lives otsuka operating concepts prevention presymptomatic healthcare matsutani line perspective think continue measures individual health management also apply covid pandemic substantial impact direction achieves sustainability otsukas control infectious diseases companies still end sight even strength solid business structure profit addition wake covid pandemic pandemic subsides individual lifestyles social conditions pharmaceutical business well culture tenaciously considerable amount business operations completely different companies required engaging creation products benefit people otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report compliance tax compliance established otsuka group global code business ethics openly convey information stance otsuka group complies otsuka group global code business ethics groups tax policy countryspecific laws related initiatives website form message president otsuka holdings furthermore regulations tax treaties well international taxation rules engage transactions designed evade formulated otsuka group global anticorruption policy expresses stance corruption sites worldwide payment taxes carries appropriate filing payment taxes country endeavor appropriately otsuka group global policy conflict interest aimed maintaining objectivity business otsuka group global disclose information ensure degree transparency trust dealing tax authorities country privacy policy defines stance guiding principles privacy protection policies form basis conducting complexity tax oversight increases businesses become global continuously updating information engaging business high ethical standards prior consultations tax experts necessary appropriately responding order minimize tax risk compliance promotion system correspondence tax authorities submissions relevant authorities also necessary otsuka group global anticorruption instill compliance group companies otsuka group otsuka group engages constructive relationships tax make use advance pricing agreements apas obtain ahead policy conducts universal training based content authorities countriesregions operates oftime consensus tax authorities otsuka group global anticorruption policy embodies policies training materials distributed operating company continue improve reliability tax data establish reiterates steadfast commitment conducting officers employees contract employees dispatched systems provide promptly governance employees operating company attend related training business integrity compliance relevant work maintain improve taxrelated governance anticorruption laws policy outlines prevent least annually submit signed declaration observe transfer pricing policy recognizing contributes enhancement regulations levels understanding compliance detect deter violations anticorruption laws sets otsuka group calculates transfer prices based oecd corporate value end active involvement penetration among employees evaluated test forth global minimum standards regarding guidelines created prevention double cfo strengthening cooperation departments training awareness surveys measures results prevention corruption applies worldwide training status submission declaration forms taxation fair application transfer price tax system operating companies well securing training business operations regularly reported meetings board directors well countrys transfer price tax system makes capable human resources thereby maintaining appropriate httpswwwotsukacomencsr operating company also established related regulations efforts ensure proper transactions related parties system enhances tax compliance reduces tax risks governancepdfotsukagroupglobalanti accordance laws country conducts legal recent years oecd issued action plan base erosion furthermore established reporting obligations corruptionpolicyirpdf compliance addition operational status internal profit shifting beps multinational corporations board directors audit supervisory committee reporting systems internal audits major group companies engage international transactions lead double non regarding abovementioned policies processes well regularly reported meetings board directors otsuka otsuka group global policy conflict taxation properly execute obligations make ongoing implementation maintenance holdings interest otsuka group recognizes conflicts interest monitoring group individual employees matter could holding company whose role maximize otsuka impact integrity organization one groups corporate value otsuka holdings established system risk management great bearing groups future based thinking ensure appropriate business operations perspective formulated otsuka group global policy conflict group whole established system facilitating interest prevent conflicts working cooperation otsuka group system affiliated otsuka group carries risk management supervision top management based recognition pursuing companies report otsuka holdings necessary regarding items management efficiency controlling risks inherent business activities important enhancing corporate value instill policy global level specified affiliated company management regulations httpswwwotsukacomencsr obtain approval relevant important items governancepdfotsukagroupglobalpolicyfo examples overseas initiatives include appointment rconflictofinterestirpdf compliance officers group company asia risk management system details risk management activities holding regular meetings sharing status progress enhance risk management otsuka holdings conducting risk assessments risk awareness management otsuka group global privacy policy country director charge compliance also visits main operating companies company introduced enterprise shared management interviews otsuka holdings recent years many countries enacted privacy companies gather information offer suggestions risk management erm july purpose main operating companies topdown approach improvements may made protection legislation european unions general recognizing assessing groupwide risks prioritizing assessments risk control conducted frontline addition internal audit department direct data protection regulation gdpr implemented may allocation resources control principal risks employees bottomup approach enables us authority president established conducts regular otsuka group working strengthen privacy part erm activities established groupwide comprehensively identify risks exist group audits based internal audit rules verify operations protection addition formulating otsuka group risk management framework system risk assessment company formulates risk management policies risk executed appropriately efficiently regard global privacy policy define stance guiding assets business general otsuka holdings affiliated identifying principal risks risk assessments management action plans risks judged principles privacy protection establish related rules companies department submits audit reports main operating companies formulating countermeasures principal risks regularly reviews risk situation review management systems accordance president directors audit supervisory board members risks progress action plans laws regulations related privacy protection cases finds need improvements department risk management activities reported risk addition otsuka holdings aggregates visualizes country issues improvement advisories follows check management committee chaired president results group company 's assessments gain httpswwwotsukacomencsr implementation status measures ascertain execution representative director company risk management comprehensive understanding risks exist duties suitably improved addition department governancepdf committee monitors principal risks examines past risk control situation group based results otsuka otsukagroupglobalprivacypolicyirpdf shares information audit supervisory board members management activities considers proposals holdings identified group 's principal risks accounting auditor coordinates unified stance improvement regularly reviews risk management system otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report risk management system item response risk management committee decisionmaking board directors chair president representative director risk related uncertainty review research development directions appropriate new drug development enhancing pipelines decisions status risk management implementation monitoring risk reduction measures reporting status monitoring status risk management forming appropriate strategic alliances making acquisitions risk management review risk management system risk related business alliances detailed due diligence valuation target companies assets extensive discussion board directors business risks related acquisitions operation monitoring investment visualization companys risk management business strategy developing inhouse talent pdca initiatives group risks adopting stateoftheart technologies conducting proofof identification risk related digitalization concept demonstrations practical application otsuka holdings groups principal risks holding seminars improve literacy providing products appropriate prices demonstrating risk related healthcare cost value new drugs containment measures contributing control soaring healthcare costs total healthcare company establishing global safety management structure risk related side effects centralized management safety information establishing system implementing safety measures plan check action compliance legal regulatory requirements governmental industry standards awareness review risk risk related food safety acquisition certifications specification monitoring management risk otsuka holdings risks formulation management management status indicators main operating identification risk activities monitoring evaluation encouraging acquisition international standard certification companies rif kh si g ah e es c h poa ln ica ieg se ne dn b ne ad g en r eis nk io nf r ii cs ak om ra snagement formulating business continuity plans awareness company action plans policies review reporting conducting regular drills action plans progress actions risk related natural disasters conducting simulated desktop simulation drills jointly among workplace risk reassessment group companies pandemics risks promotion measures covid establishing enhancing workfromhome system web conferencing systems risks related fair equitable transparent procurement building good relationships suppliers production risk related supply chain ensuring stable procurement supply raw materials principal risks marketing products disruption conducting risk assessments groupwide risk assessments otsuka group recognizes business risks establishing systems ensure business continuity event following principal risks otsuka holdings key operating httpswwwotsukacomenirmanagementriskhtml covid pandemic companies taking steps mitigate purchasing raw materials multiple companies gathering information market trends securing risk related raw material price alternative raw materials item response increases maintaining appropriate inventories reducing costs improving productivity establishing otsuka global academy talent recruitment declaring diversity promotion otsuka group global code focusing research development new products risks related development risk risk related expiration business ethics providing relevant systems mechanisms drive sustainable growth management based patent protection initiatives extend lifecycle products determining materiality resolving social issues business corporate philosophy risk related corporate social activities responsibility risk related patent establishing management system intellectual property rights establishing otsuka group sustainability promotion committee infringement conducting investigations gathering information strategic allocation managerial resources measures establishing internal reporting system business risk related litigation cooperation outside counsels etc establishing otsuka group global code business ethics risk holding company related global policies establishing otsuka group global information security policy risks related upgrading internal monitoring framework establishing risk related information education training executives employees groupwide internal reporting system management business strategy establishing group information security committee ensuring financial soundness risks related risk related corporate brand establishing ci management committee business management r oi ps ek r r ae tl ia ot ne sd global business bap sp er p ni tt e loa cn aa l g oe pm ere tt gn ed n vu ip rop mrt e f tr business operations inhouse training management reputation formulating otsuka group pr guidelines risk related foreign exchange use forward exchange contracts stock prices diversified periodic review portfolio otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report esg content index details sustainability initiatives visit httpswwwotsukacomencsr addition information included integrated report otsuka group discloses following esgrelated information website please visit website details item policies commitments systems initiatives item policies commitments systems initiatives overall signatory united nations global compact sales basic policy pages conducting appropriate marketing promotion activities compliance laws sustainability mission marketing establishing internal code practice expand regulations materialities pages jpma promotion code prescription drugs activities gathering disseminating information products related knowledge latest goals progress pages targeted healthcare professionals academic information etc stakeholder engagement structural measures establishing scientific employee training sustainability management structure pages affairs department gathering disseminating reducing food loss extending shelf life switching monthbased expiration dates external recognition information products related knowledge etc datapeople environment governance latest academic information dedicated review unit ensure appropriate marketing promotion activities society health basic policy customer service basic policy pages promoting customercentric management pharmaceutical basic policy contribution unmet medical needs pages declaration customercentric commitment ensuring appropriate communication customers business goals progress pages initiatives access medicine improved products based customer feedback fy goals quantification fy progress initiatives infectious diseases including tuberculosis groupwide customer service liaison meeting cross establishing dedicated contact points patients healthcare professionals department listen customer feedback meeting customers respectively nutraceutical basic policy catering yettobeimagined needs promotion structures consumercentric business goals progress pages initiatives access nutrition pages management environment environmental otsuka group global code business ethics environmental protection people basic policy management otsuka group environmental policy otsuka group environmental activity guidelines human resource basic policy human resource development programs including management human resource group promotional structures centering otsuka group global environmental council development development programs disclosure iso certification status internship programs systems leveraging abilities open recruiting system selfassessment system etc climate change basic policy initiatives efficient energy use co reduction expanded use renewable goals progress pages energy sources introduction cofree electricity including solar power diversity otsuka group global code business ethics diversity diversity generation inhouse consumption purchase green power certificates inclusion inclusion systems diversity promotion including mindset establishing structure help etc pages basic policy diverse human resources play active roles regardless nationality race age gender validation goals science based targets sbt initiative signatory womens empowerment principles weps disability sexual orientation etc disclosure co emissions data iku boss managers supportive worklife balance examples external recognition declaration group companies resource basic policy initiatives achieve zero waste recycling goals progress pages initiatives plastic resource marine plastic pollution health otsuka group global code business ethics initiatives employee health maintenance promotion disclosure waste volume effective use volume final disposal volume safety human rights labor standards employee initiatives workplace health safety conservation data health initiatives reduction overtime encouraging employees take paid leave basic policy examples external recognition water basic policy water risk evaluation manufacturing sites pages declaration health group companies conservation goals progress pages disclosure water usage water use efficiency data health safety committee promotion structures governance corporate basic policy fair employment otsuka group global code business ethics internal training bullying harassment issues governance corporate governance guidelines working h ah ru asm sman e nr tig h n dn r l ea pb oo rr nt ga n cd oa nr cd es r n iscrimination employee survey improvement activities based survey results governance basic policy disclosure corporate governance report condition basic policy structure overview governance structure initiatives strengthen corporate governance board directors audit supervisory board corporate governance committee human rights otsuka group global code business ethics implementing human right risk assessment identify salient human right risks initiatives h ah ru asm sman e nr tig h n dn r l ea pb oo rr nt ga n cd oa nr cd es r n iscrimination wde hn ist tif ley bin log w sa inli ge n ht h tlu inm ean right issues implementing corrective measures sr ka li lo mna al te ri xfo fr r e dle irc et cio ton r f nd dir e ac uto dr sd u e pv ea rvlu isa oti ro yn b rb mar ed e bff ee rc st ive pn ae gs es page basic policy employee training otsuka group human rights policy succession plan otsuka group human rights policy external collaboration promotional structure remuneration basic policy disclosure corporate governance report directors remuneration standards system method determination quality basic policy audit otsuka group global code business ethics business integrity maintaining books records etc supervisory certification status iso quality iso fssc food safety etc board members research commitments rd compliance laws ethical considerations research involving animals development guidelines ethical considerations etc pages ethical considerations research involving humanderived specimens compliance overall basic policy ethical considerations research involving pathogenic microorganisms pathogens compliance promotion structure genetically modified organisms ethics clinical trials tax compliance basic policy correspondence tax authorities compliance rd otsuka group companies tax policy management public research funds transfer pricing policy procurement basic policy pages promotion sustainable procurement consideration environment anticorruption otsuka group global code business ethics bribery due diligence otsuka group procurement policy human rights matters corruption etc training employees otsuka group sustainable procurement guidelines including due diligence investigation new suppliers common saq otsuka group global anticorruption policy monitoring sustainable procurement promotional structure briefing sessions business collaborators pages establishment otsuka sustainable procurement task joint business collaborator audit pharmaceutical companies conflicts otsuka group global code business ethics conflicts training employees force pages global initiatives streamlining production supply products interest interest etc monitoring goals progress pages otsuka group global policy conflict interest production basic policy pages production quality control patientcustomer safety compliance protecting otsuka group global code business ethics privacy training employees quality control measures including global product quality policies regulatory requirements governmental industry standards privacy confidentiality etc monitoring pharmaceutical products otsuka pharmaceutical acquisition iso quality iso fssc food safety etc otsuka group global privacy policy patient promotion structure including global production meeting quality control based gqp gvp postmarketing safety management customer safety global product quality meetings global implementation pharmacovigilance activities whistleblowing provision internal external whistleblowing hotlines measures falsified medicines hotline employee training risk overall basic policy identifying principal risks via risk assessments mitigating risks pages logistics eb sa ts aic b lp iso hl micy e nt p oa fg te hs e g p promotion office win ii tt hia ti hv ee g f oo dq u da il si tt ry bc uo tn iotr l p ran cd im cea gt den pa n gc ue id ep lr ino em ei mon p lo l eo eg tis rt ai ic ns nin g c eo tm cp liance management r enis tk e rm pra sea g rie sm k men n p ao gl eic ent b ru iss ki n ass n aco gn emtin eu ni tt rp al ia nn inn ging management promotion structures control maintenance initiatives streamlined cooperation among shippers distributors risk management system operated risk initiatives mitigate information security risk product quality stable supply logistics standardization itbased data systems digitization forms etc management committee initiatives stable supply distribution strage inventory registration vehicles authorized access restricted areas etc contribution communities policy activities contribute communities environmentally friendly measures promotion modal shift reduce co emissions otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report financial nonfinancial highlights visit otsuka holdings website key sustainability data httpswwwotsukacomencsrdatapdfmajorcsrdataenpdf revenue overseas revenue ratio business profit business profit margin ratio revenue number employees number female managers female manager ratio revenue overseas revenue ratio business profit business profit margin number employees number female managers female manager ratio billion billion plan plan revenue left overseas revenue ratio right business profit left business profit margin right outside japan japan number female managers left female manager ratio right scope production sites consolidated otsuka group scope fiscal six companies otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka warehouse otsuka chemical otsuka foods fiscal nine companies six companies plus otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite fiscal eleven companies nine companies plus otsuka holdings otsuka medical devices profit attributable owners company return pharmaceutical business equity attributable owners company roe rd expenses rd ratio ratio revenue number employees taking parental leave co emissions co emissions per sales profit attributable owners company return equity attributable owners company roe rd expenses pharmaceutical business employees taking parental leave total co emissions billion billion thousand tonsco tons million japan indonesia india north america south korea china europe others plan plan profit attributable owners company left rd expenses left female male total co emissions left co emissions per sales right return equity attributable owners company roe right rd ratio right scope fiscal six companies otsuka pharmaceutical otsuka pharmaceutical factory taiho scope production sites consolidated otsuka group excluding impairment losses pharmaceutical otsuka warehouse otsuka chemical otsuka foods fiscal nine companies six companies plus otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite fiscal eleven companies nine companies plus otsuka holdings otsuka medical devices total assets ratio equity attributable simple incineration landfill volume owners company total assets annual dividend per share dividend payout ratio water usage water use efficiency total waste volume total assets annual dividend per share water usage water use efficiency total waste volume billion thousand million tons tons japan southeast asia east asia south asia north africa north america south america europe plan total assets left annual dividend per share left water usage left water use efficiency right simple incineration landfill left total waste volume right ratio equity attributable owners company total assets right dividend payout ratio right scope production sites consolidated otsuka group scope production sites consolidated otsuka group otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report main data effect fiscal ended december otsuka adopted international financial reporting standards ifrsinformation fiscal ended december also presented line ifrs jgaap ifrs ifrs item unit unit results operations revenue billion us million selling general administrative billion us million expenses business profit rd expenses billion us million ratio business profit rd expenses revenue rd expenses billion us million rd ratio business profit billion us million business profit margin operating profit billion us million operating profit margin profit attributable owners company billion us million financial position total assets billion us million total equity billion us million ratio equity attributable owners company total assets roe cash flows net cash flows operating activities billion us million net cash flows used investing billion us million activities free cash flows billion us million dividends annual dividend per share yen us dividend payout ratio common stock stock price thousand thousand number shares outstanding yearend shares shares stock price yearend yen us number employees total persons persons japan persons persons outside japan persons persons line items based ifrs sga expenses jgaap presented total expenses less rd expenses company believes information useful investors comparing companys financial results jgaap ifrs excluding impairment losses business profit revenue cost sales selling general administrative expenses share profit associates rd expenses due change consolidated fiscal year fiscal ended december transitional period covering nine months april december december company finalized provisional accounting treatments business combinations reflected presentation figures year ended december calculated us number employees including otsuka holdings co ltd subsidiaries otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report corporate information global network group structure overview main operating companies corporate profile company organization december april otsuka group corporate philosophy company otsuka holdings co ltd name established july capital billion overview otsuka group companies whose origins date back aims contribute health people around world aims two main pillars pharmaceutical business diagnosis treatment diseases nutraceutical business head office kandatsukasamachi chiyodaku tokyo support maintenance promotion everyday health japan companys culture summarized words ryukangodo sweat recognize way jissho actualization sozosei creativity fostered successive otsuka leaders emphasized employees across group companies countries regions strive create market unique products services tokyo shinagawa grand central tower konan headquarters minatoku tokyo japan nutraceuticals nutritionpharmaceuticals end december otsuka holdings subsidiaries affiliates telephone organizational structure otsuka holdings number consolidated employees otsuka pharmaceutical otsuka pharmaceutical taiho pharmaceutical otsuka warehouse otsuka chemical otsuka foods otsuka medical factory devices business control management related activities description respect companys subsidiaries affiliates operating pharmaceutical nutraceutical consumer product businesses europe companies north japan america otsuka operates asia companies middle east companies countriesregions south companies central america oceania companies companies gniteem sredloherahs srotcerid fo draob namriahc tnediserp internal control department internal audit department nutraceutical business global strategy planning headquarters corporate planning department global business support department finance accounting department project office tax department corporate service department business development department investor relations department administration department president office public relations department sustainability promotion department human resources department human resource planning department planning department legal affairs department statutory auditors board statutory statutory auditors office auditors otsuka pharmaceutical total healthcare company supporting wellbeing whole body co ltd treatment diseases promotion everyday health corporate philosophy otsukapeople creating new products better health worldwide otsuka pharmaceutical operates two core businesses pharmaceutical business supports diagnosis treatment diseases nutraceutical business helps people maintain improve daytoday health global network otsuka pharmaceutical original company otsuka group leader iv solutions december factory inc japan years experience field based management vision best partner clinical nutrition otsuka pharmaceutical factory creates innovative products meet variety needs including pharmaceuticals medical devices oral rehydration solutions medical foods otc pharmaceuticals company operates globally focus japan rest asia taiho pharmaceutical pioneer oral anticancer agents japan half century co ltd taiho pharmaceutical rddriven specialty pharma focusing fields oncology allergy immunology urology corporate philosophy strive improve human health contribute society enriched smiles oncology field particular taiho pharmaceutical known one leading companies japan actively promoting globalization well consumer healthcare business taiho pharmaceutical strives research develop novel unique products continuing identify people 's real needs meeting precisely otsuka warehouse contributing peoples health worldwide field logistics co ltd since founding otsuka warehouse developed businesses emphasis pharmaceutical food product logistics includes constructing common distribution platform otsuka groups three core categories pharmaceuticals foods beverages daily necessities recent years otsuka warehouse working extend logistics solutions outside group otsuka chemical otsuka chemical creatively gives shape power materials together customers co ltd materials core operations otsuka chemical aims continuous technological innovation leads creation products enable higher standards living otsuka chemical provides products global markets automotive electrical electronic equipment housing healthcare areas main segments hydrazine business advanced polymer materials business inorganic composite materials business pharmaceutical intermediates active pharmaceutical ingredient api business otsuka foods co ltd creating highvalueadded products offer new dietary lifestyles since otsuka foods motto company begins people food begins spirit mind employees bring spirit food focused deliciousness safety peace mind better health businesses today social landscape changing dramatically super aging societies health environmental population issues many issues leveraging brand otsuka foods continue pursue solutions address kind social change creating providing products customers need seeking contribute people world otsuka medical devices developing innovative treatment methods creating new value co ltd since establishment february otsuka medical devices co ltd focused developing unique solutions improve health well patients whose medical needs conditions yet fulfilled existing treatment methods achieve aspiration becoming pioneer medical device industry combine global rd efforts technology drug discovery knowhow inherent within otsuka group 's heritage otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report disclosure otsuka group stock information december otsuka group provides overview financial nonfinancial information number shares authorized shares principal shareholders top integrated report visit otsuka holdings website additional information including consolidated number shares issued shares number shareholding financial statements financial results presentations supplementary documents information number shareholders name shareholders shares held ratio thousand research development nomura trust banking co ltd otsuka founders shareholding fund trust account master trust bank japan ltd trust account website investor relations httpswwwotsukacomen httpswwwotsukacomenir stock distribution custody bank japan ltd trust account treasury shares securities otsuka estate co ltd companies otsuka group employee shareholding fund companies awa bank ltd financial institutions jp morgan chase bank otsuka asset co ltd jpmorgan securities japan co ltd custody bank japan ltd trust account individuals others foreign notes number shares held rounded nearest thousand corporations although company holds shares treasury shares otsuka groups sustainability excluded list shareholding ratio calculated treasury shares deducted httpswwwotsukacomencsr japan trustee services bank ltd merged trust custody services bank ltd jtc holdings ltd july changed trade name custody bank japan ltd maximumminimum stock price volatility year total shareholders return maximum minimum volatility fiscal fiscal stock price stock price standard deviation otsuka holdings comparison topix total return index integrated report precautions regarding forwardlooking statements beginning fiscal edition otsuka holdings combined integrated report summarizes operating financial results annual report csr report single integrated report brings otsuka group otsuka holdings co ltd subsidiaries fiscal together financial information nonfinancial information hope january december report contains deepens stakeholders understanding group aim become forwardlooking statements forecast pertaining plans projections indispensable contributor peoples health worldwide strategies performance otsuka group companies statements based upon current analysis beliefs light reporting period information available issuing date report actual results may stock performance fiscal january december therefore differ due risks uncertainties may affect otsuka note certain information january onward also included group operations stock price left trading volume right thousand shares scope reporting medical information principle report covers otsuka holdings co ltd integrated report sake readability unified brand name subsidiaries scope activities data narrower details used product different brand names different countries noted regions therefore products may available countries may available different brand names different indications guidelines referenced different dosages strengths international integrated reporting framework international integrated please note information regarding pharmaceutical products reporting council iirc including products development intended advertising gri sustainability reporting standards global promotional purposes medical advice reporting initiative gri iso environmental reporting guidelines ministry environment guidance collaborative value creation ministry economy trade industry guidelines otsuka holdings co ltd integrated report otsuka holdings co ltd integrated report integrated report year ended december responsible management forest resources report printed paper produced fsccertified sources accordance standards forest stewardship council international certification body dedicated promoting responsible forest stewardship controlled sources using nonvoc ink free mineral oils